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The microflora inhabiting the human gastrointestinal tract can be considered an 
essential ‘metabolic organ’, in a symbiotic relationship with its host. Due to the low 
cultivability and inappropriate sampling methodology the microflora is poorly 
explored and ill-defined. 
Preliminary, molecular-based research at the University of Waikato revealed the 
presence of 16S rRNA gene sequences originating from novel Mollicute-like species 
inhabiting the human GI tract. A ~830bp ‘consensus’ sequence representing these 
novel Mollicute-like sequences was classified within the Mollicute Genus
Anaeroplasma the type species of which is Anaeroplasma abactoclasticum. It also
displayed near exact matches with 16S rRNA sequences obtained from the human GI 
tract and matches of high similarity to those from the mouse GI tract in the NCBI 
database.
This thesis describes an attempt to design and create primers that would amplify and 
characterize full-length versions of these Mollicute-like sequences from samples 
obtained from the mucosal surface of the human gastrointestinal tract. Primers sets
targeted extended 5’ and 3’ versions of these novel ‘known’ sequences and were 
designed from sequence matches found in the preliminary work and other related 
sequences from the NCBI database.
The attempt to amplify a full-length version of these novel Mollicute-like sequences 
was proven to be unsuccessful. No sequences were classified within the Genus 
Anaeroplasma, although 81% of amplicons from the 5’ extending primer sets were 
classified within the same division as the Mollicutes, the Firmicutes, only 6% of the
sequenced amplicons from the 3’ extending primer set belonged to this division. 
Phylograms containing these ‘relevant’ sequences and the ‘consensus’ sequence 
grouped the ‘consensus’ sequence separately, indicating a lower relatedness than 
would have been seen if any of the amplicons contained the ‘consensus’ sequence.
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Chapter 1: Literature Review
1.1 Introduction
1.1.1 The Human Gastrointestinal Tract
Humans have evolved a complex symbiotic relationship with the trillion or more 
(1013 to 1014) anaerobic micro-organisms inhabiting the distal regions of their 
gastrointestinal (G.I) tract (Gill et al., 2006). Collectively known as the gut 
‘microflora’, these microbes endow their human hosts with fundamental genetic and 
metabolic properties that they have not had to evolve themselves, contributing 
significantly to their health and well-being (Backhed, Ley, Sonnenburg, Peterson, & 
Gordon, 2005; Turnbaugh et al., 2007). Some of these properties include: the 
catabolism of polysaccharides, the provision of essential nutrients (e.g. vitamin K), 
protection against epithelial cell damage and pathogenic infection, immunity, 
regulation of host fat storage and protection against the development of G.I. cancer
(Eckburg et al., 2005). These properties taken into account along with the shear 
number of micro-organisms, it is of no surprise that many consider the gut’s 
microbiota to be a ‘metabolic organ’ (Turnbaugh et al., 2007), located within a  
‘Superorganism’ (Gill et al., 2006). ‘Superorganism’ is a term used throughout the 
relevant literature in reference to the human body, describing it as a composite of 
human and microbial cells, hence, the human genetic landscape is seen as a 
collaboration of the human genome and the genomes of the resident microflora 
(collectively termed the ‘microbiome’)(Gill et al., 2006).
1.1.2 Studying the microflora
It is widely accepted that up to 99.8% of the microbes present in many environments 
are not readily culturable (Streit & Schmitz, 2004), and with the G.I tract playing host 
to a plethora of microenvironments, it is understandable that its microflora is poorly 
studied and ill-defined to date. With the current limitations of laborious and costly 
culture based techniques and continuing advancements and utilisation of DNA-based 
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molecular research, headway has been made in determining the genetic composition 
of the microflora, described as the ‘microbiome’. 
1.1.3 Studying the microbiome 
The microbiome is estimated to contain ≥100 times as many genes as our 2.85-billion 
bp human genome (Gill et al., 2006), determining its composition is an enormous 
task, one which has being addressed via ‘metagenomics’. 
‘Metagenomics’ (synonymous with Environmental Genomics, Ecogenomics or 
Community Genomics)  is a term that encompasses various approaches taken in the 
direct genomic analysis of the microbial communities inhabiting an environmental 
sample with the aim to access their genomic potentials, while bypassing the isolation 
and cultivation of individual species.(Naomi, 2006). At present this is done by 
isolating DNA from an environmental sample, cloning the DNA into a vector, 
transforming the clones into a host bacterium, and screening the transformants that 
result (Figure 1.1-A). The clones can then be screened for phylogenetic markers for 
instance 16SrRNA or rpoB, or other conserved genes by hybridisation or multiplex 
PCR, or expression of specific traits, for example antibiotic production, or they can 
be sequenced randomly (Handelsman, 2004).
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Figure 1.1-A: Flowchart summarising the ‘Metagenomic Process’ (Handelsman, 2004).
1.1.3.1 Metagenomic Libraries
Whole-genome shotgun sequencing and assembly has been applied to diverse 
microbial communities including the microbiome. This approach has been validated 
in work by (Venter et al., 2004), and works on the premise that sequences belonging 
to abundant species will be soundly represented in random shotgun sequencing data, 
whereas species of lower abundance will be represented to a lesser extent (Gill et al., 
2006).
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Libraries of whole-genome shotgun sequences retrieved from two adult human fecal 
samples were assembled and analysed by (Gill et al., 2006), in an attempt to analyse 
the human distal gut microbiome.  In this study ~78 million bp of DNA sequence was 
obtained, of which 33,753,108bp belonged to 17,668 contigs which were assembled 
into 14,572 scaffolds. The remaining 45,078,063bp of DNA couldn’t be assembled 
into contigs; this is thought to be related to the depth of sequence coverage and the 
low relative abundance of the organisms from which the sequences were derived. A 
total of 50,164 open reading frames (ORFs) were predicted in the data set, with 
19,866 being unique; 589 contigs were assigned to Archaea and 13,130 to Bacteria. 
All other contigs didn’t have matches with any known ORF’s or gave ambiguous 
results. The ability of this metagenomic method to define an environment’s diversity 
was shown in the comparison of shot-gun sequences to a sequenced genome. This 
was done with the lactic acid producing bacterium Bifidobacterium longum; 1965 
reads, representing 1,617,706bp of relevant sequence was compared to, and covered 
~0.7% of the B. longum genome. 52% of the reads had less than 95% identity when 
aligned with the genome sequence (Figure 1.1-B). These results give reason to 
believe that these reads did not originate from a single strain, but rather from multiple 
strains, hence giving insight into the diverse nature of the microbiome.
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Figure 1.1-B: Displays the diversity within the microbiome, using one species and its multiple strains, 
all of which were found using shotgun sequencing methodology. Percentage identity plot of the 
sequence alignments between the relevant random reads obtained from human fecal samples and the 
completed genome of Bifidobactrium longum. The x axis represents the coordinate across the genome, 
and the y axis represents the percentage identity of the match (Gill et al., 2006).
1.1.3.2 Phylogenetic Determination using 16SrRNA
Ribosomal RNA’s are part of the machinery required for DNA translation during 
protein synthesis. The ribosome of Prokaryotes is 70 Svedberg (S) units in size and is 
composed of two subunits, the large subunit 50S (contain the 5S rRNA and the 23S 
rRNA) and the small subunit 30S (contains 16S rRNA molecule). Due to the 
complexity of its structure and function of the rRNA molecules, ribosomal RNA 
genes are highly conserved and are employed in the measurement of evolutionary 
relationships among organisms. 16S rRNA has become the most widely used of the 
rRNAs in the assembly of Prokaryote phylogenies, this is attributable to the choice of 
variable regions where the sequence differs markedly within the 16S rRNA gene. 
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Variable regions are unique to a particular organism or organisms, therefore they 
allow the identification and phylogenetic positioning of bacteria (Blaut et al., 2002; 
Turnbaugh et al., 2007). 16S rDNA data is integral to the determination of the human 
gut microflora’s composition, work of such nature was undertaken by (Eckburg et al., 
2005).
(Eckburg et al., 2005) obtained human mucosal samples from the: caecum, ascending 
colon, transverse colon, descending colon, sigmoid colon, and the rectum of three 
healthy adult patients undergoing colonoscopy; fecal samples were collected 1 month 
later. Their aim was to characterise the adherent microbial populations and make 
comparisons between the subjects and mucosal sites using 16S rDNA sequences. 16S 
rDNA was amplified by polymerase chain reaction, for bacterial 16S rDNA 
amplification the primers used were: Bact-8F (5’-AGAGTTTGATCCTGGCTCAG-
3’) and Bact-1391R (5’-GACGGGCGGTGTGTRCA-3’). All 21 samples yielded 
bacterial products; these were cloned, bi-directionally sequenced and subjected to 
numerical ecology approaches.
11,831 near-full length, non-chimeric, bacterial 16S rDNA sequences underwent 
phylogenetic analysis; with the parameter of 99% minimum similarity within a 
phylotype, 395 bacterial phylotypes were determined (Figure 1.1-C). 244 (62%) of 
these were novel phylotypes and 80% had not been cultivated at the time of 
publication (2005). The majority of organisms belonged to the two bacterial phyla of 
the Firmicutes and Bacteriodetes. The Firmicutes phylum was represented by 301 
phylotypes, 191 of them were novel and the bulk of them (95%) belonged to the 
Class Clostridia, while 4.5% were Mollicutes, 13 of the 20 Mollicute phylotypes 
found were novel. Interestingly, there was a large variation between Bacteriodetes
phylotypes between subjects.
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Figure 1.1-C: Phylogenetic tree based on a combined human intestinal 16S rDNA sequence data set. 
The label for each clade includes, in order, the total number of recovered sequences, phylotypes, and 
novel phylotypes (in parentheses). 20 Mollicute phylotypes were found, 13 of which were novel. The 
angle where each triangle joins the tree represents the relative abundance of sequences, and the lengths 
of the two adjacent sides indicate the range of branching depths within that clade (Eckburg et al., 
2005).
1.1.3.3 Defining the Human Gut Microflora from Fecal Samples
Much of the early data used in the assistance of defining the human gut microflora 
has been derived from fecal samples, yet there has been little exploration into the 
possible differences that might occur between fecal and mucosal communities, 
between sites and between subjects. (Eckburg et al., 2005) took relative abundance 
and genetic divergence of sequences within communities and applied the statistical 
method of double principal coordinate analysis (DPCoA) to access the 
aforementioned differences. The findings displayed significant interpersonal 
differences, differences between mucosal and fecal compositions, and fewer 
differences between intrapersonal sampling sites (Figure 1.1-D). 
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Figure 1.1-D: DPCoA for (A) colonic mucosa (solid lines) and stool (dashed lines), (C) colonic 
mucosal sites alone, and (D) mucosal sites excluding Bacteroidetes phylotypes. Phylotypes are 
represented as open circles, colored according to phylum. Phylotype points are positioned in 
multidimensional space according to the square root of the distances between them. Ellipses indicate 
the distribution of phylotypes per sample site, except in (A), where all mucosal sites are represented by 
one ellipse. Percentages shown along the axes represent the proportion of total Rao dissimilarity 
diversity coefficient (which accounts for both phylotype abundance and dissimilarity), captured by that 
axis. (A) Is the best possible two-dimensional representation of the Rao dissimilarities between all 
samples. (B) Is an enlarged view of (A), depicting the centroids of each site-specific ellipse. Subject 
ellipse distributions remain distinct after stool phylotypes (C) and Bacteroidetes phylotypes (D) are 
excluded from the analysis, as so many phylotypes were already found to vary between subjects 
(Eckburg et al., 2005).
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1.1.4 Determining the Functionality of the Gut Microflora
Many functions of the microflora have been determined in the past, many of which 
have already been mentioned. Despite this, with such an incomplete knowledge of the 
composition of the microflora it is expected that much of the functionalities of the 
organisms that comprise it are yet to be determined. Consequently, this lack of 
understanding has motivated investigations into the microflora’s functionality. The 
ascertainment of many of these potential functions could very well lend hand to 
various fields, particularly those of medicine and pharmacology.
1.1.4.1 The Human Gut Microflora and Obesity
The importance of understanding the functionality of the human gut microflora comes 
to light in work carried out by (Backhed et al., 2004; R. E. Ley et al., 2005; R. E.  
Ley, Turnbaugh, Klein, & Gordon, 2006).
(Eckburg et al., 2005; Gill et al., 2006) used the mouse obesity model, where, 
genetically obese ob/ob mice, lean ob/+, lean wild-type +/+ siblings and their lean 
ob/+ mothers were raised on polysaccharide-rich diets. As the gut’s microbial 
community was inherited from their mothers, it was an opportunity to measure the 
composition and any changes in that composition between the lean and obese mice. 
Molecular analyses of 16S rRNA sequences amplified from the caecum of the mice 
showed that the distal gut is dominated by the presence of two bacterial divisions, the 
Bacteriodetes (20-40%) and the Firmicutes (60-80%). These results were compared 
to 16S rRNA sequences amplified from the human colon using the same primers as 
with the mice, with significant similarities between them at this division level (Figure 
1.1-E).
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Figure 1.1-E: Phylogenetic tree displaying the bacterial Divisions. Those found in the mouse gut are 
represented with a mouse symbol, while those from the human gut are represented with a human-head 
symbol. Divisions labeled ‘H’ are those found in human fecal samples. Dominant Divisions from both 
Mice and Humans are labeled in red (Bacteriodetes and Firmicutes), rarer Divisions are blue, and 
undetected Divisions are black (R. E. Ley et al., 2005).
It has also been shown that a decrease in the Bacteriodetes to Firmicutes ratio leads to 
an increase in the efficiency with which food is converted and stored as fat by 
microbial manipulations of physiological and metabolic pathways (Backhed et al., 
2005; R. E. Ley et al., 2005; R. E.  Ley et al., 2006). Higher proportions of the 
Firmicutes division were found in the genetically obese mice (Figure 1.1-F).
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Figure 1.1-F: Graph depicting the percentage of sequences found in the caecal contents of each of the 
transgenic siblings from the mouse obesity model. The ob/ob obese siblings has a higher ratio of 
Firmicute sequences to Bacteriodetes, while it’s lean (+/+, ob/+) have a markedly less obvious 
difference in ratio, and a higher amount of Bacteriodetes sequences than that of the obese individual. 
(R. E. Ley et al., 2005).
This microflora  has been suggested to contribute to obesity by an increased 
efficiency in food conversion to fat, despite a lowered quantity of food intake and 
increased overall metabolic rate in comparison to their normal littermates (R. E. Ley 
et al., 2005). (P. J. Turnbaugh et al., 2006) transplanted the microbiota from the 
caecum of obese (ob/ob) or lean (ob/+) mice into adult germ-free mice. 16S rRNA 
sequence analysis confirmed the obese ob/ob donor’s microbiota had a higher 
proportion of Firmicutes to Bacteriodetes than the lean ob/+ donor, concordant with 
the aforementioned studies. Figure 1.1-G, displays the comparison between the ceacal 
contents of the recipients. Figure 1.1-G (a), there was higher amount of short-chain 
fatty acids present in the ob/ob recipients implying a greater conversion of 
carbohydrate to fats; (b) there was also less energy in the feces of the ob/ob recipients 
implying a greater efficiency harvesting energy from food than the ob/+ recipients; 
(c) recipients of the transplanted ob/ob microbiota gained significantly more fat (%) 
than the recipient of the ob/+ microbiota.
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Figure 1.1-G: (a) Gas- chromatography mass-spectrometry quantification of short-chain fatty acids 
found in the caecal content of both lean (+/+, ob/+) and obese (ob/ob) mice. (b) Bomb calorimetry of 
the gross energy content (kcalg-1) of feces from both lean and obese mice. (c) Increase of body fat (%) 
between lean and obese mice. (P. Turnbaugh et al., 2006)
A decrease in Firmicutes and an increase in Bacteriodetes in the human G.I tract has 
been correlated with weight loss in obese individuals when undergoing calorie 
restricted diet regimes (R. E.  Ley et al., 2006). In work by (R. E.  Ley et al., 2006)12 
obese individuals were restricted to either fat-restricted (FAT-R) or carbohydrate-
restricted (CARB-R), low calorie diets. 16S rRNA data was collected over the course 
of 1 year from fecal samples as means of keeping track of any changes in the 
composition of their gut microbiota. Figure 1.1-H is taken from this work, (a) 
displays the consistency of bacterial lineages within people over time, with 
intrapersonal differences being significantly less than interpersonal differences, this 
information is complemented above in Figure 1.1-D (Eckburg et al., 2005). (b) Shows 
the slight decrease of Firmicutes and steady increase in Bacteriodetes sequences 
found in samples over time. This increase in Bacteriodetes also correlated with 
weight loss, as can be seen in (c). 
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Figure 1.1-H: (a) 16S rRNA sequences taken from fecal contents of two obese human subject groups 
over time (T0, baseline; T1, 12 weeks; T2, 26 weeks; T3, 52 weeks),  one group had a fat-restricted 
(FAT-R) diet, while the other had a carbohydrate restricted diet (CARB-R) both diets were calorie 
restricted. (b) Relative abundance of Firmicute to Bacteriodetes sequences averaged from all samples 
taken over time. (c) Change in relative abundance of Bacteriodetes in subjects with weight loss above 
a threshold of: 2% for CARB-R diets and 6% for FAT-R diets (R. E.  Ley et al., 2006). 
With the increasing importance of finding ways to combat obesity in the western 
world, this research could be seen as an opportunity to further understand the 
microflora component of this diverse syndrome.  They also reinforce the view that 
manipulation of the gut’s microflora can contribute significantly to human health.
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1.2 Preliminary Analysis
1.2.1 Discovery of a Novel Mollicute-like Sequence
Culture independent, molecular based research undertaken at the Institut Pasteur and 
The University of Waikato, has revealed the presence of a novel Mollicute inhabiting 
the human gastrointestinal tract and suggested to be associated with the mucosal 
surfaces of  the Esophagus, Stomach, Colon and Ileum. The research was initiated by 
the procurement of three healthy gastrointestinal mucosal tissue samples from each of 
nine elderly male patients undergoing gastrointestinal surgery for the treatment of 
various cancers; these were accompanied by further DNA samples, which were 
gained from the fecal matter of two healthy French teenagers. These samples were 
supplied by Francoise Rieu-Lesme (Rieu-Lesme, Delbes, & Sollelis, 2005).
(Kubs & Musgrave, 2007) extracted total DNA from both the tissue and fecal 
samples was amplified using the primer set: 109F (5’ 
ACGGCTTSAGTAAACRCGTRG 3’) and 927R (5’ CCR KYC AAT TCC TTT 
AAG TTT C 3’), which resulted in the amplification of a ~830bp region of the 
bacterial 16S rRNA gene. These amplicons were cloned into plasmids then sequenced 
or sequenced directly from their PCR products, using M13F/M13R or 109F/927R
respectively. Sequencing results were edited in Chromas prior to analysis using 
BLAST from the NCBI website and Classifier from the RDPII website. 
A number of polymorphisms were also identified in the novel Mollicute-like 
sequences, which suggested that not only had a new genus being identified but 
closely related stains had also being identified (Table 1.2-A). Phylogenetic clustering 
of the Mollicute-like sequences also suggested interpersonal diversity, with sequences 
from individuals grouping together in Figure 1.2-A.This detail has been found in 
other studies that have explored the interpersonal differences in the human gut 
microflora (Figure 1.1-D) (P. J. Turnbaugh et al., 2006).
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Table 1.2-A: Potential polymorphisms from all “full-length” sequences. “ConSeq”= ‘Consensus’ 
sequence. “Position”= the position of the nucleotide difference, numbering corresponds with the 
JalView alignment. B= no nucleotide. “.”= same nucleotide as the consensus sequence (Kubs & 
Musgrave, 2007).
Figure 1.2-A: The interpersonal diversity of the Mollicute-like sequences is displayed in this 
phylogenetic tree. The tree was calculated from all of the “full-length” Mollicute-like polymorphisms 
using JalView % identity .(Kubs & Musgrave, 2007).
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BLAST submission for all full length sequences, and most partial length sequences, 
gave ‘best hits’ with a 16S rRNA gene from an uncultured bacterium clone 
RL386_aao86c09 or an uncultured bacterium clone RL386_aao86h04 16S ribosomal 
RNA gene, partial sequence (P. J. Turnbaugh et al., 2006), this sequence was then 
Classified within the Mollicute Genus Anaeroplasma (94% confidence), the type 
species of which is Anaeroplasma abactoclasticum an anaerobic Mollicute found in 
the caecal contents of some mammalian species (S. Razin, Yogev, & Naot, 1998).
A consensus sequence ‘DM1 Consensus’ was constructed from the Mollicute-like 
sequences taken from one individual (DM1) and was used as a representative for all 
of the relevant Mollicute-like sequences. This was credible due to the fact the DM1 
consensus sequence was virtually identical to the total consensus sequence from 
(Kubs & Musgrave, 2007). 
1.2.1.1 The Novel Mollicute-like Sequence and Obesity Studies
The DM1 consensus sequence was submitted to the non-redundant BLAST database 
in October 2007, its ‘best hit’ was with the uncultured bacterium clone 
RL386_aao86c09, a sequence submitted from the work (R. E.  Ley et al., 2006). A 
phylogenetic tree constructed from the BLAST results and utilising a neighbor 
joining algorithm within the NCBI BLAST results webpage is displayed in Figure 
1.2-B. It shows the DM1 consensus sequence (Iclj7127, highlighted in yellow) is 
most closely related to the sequences obtained from the human (R. E.  Ley et al., 
2006) and is similar to sequences obtained from the mouse gastrointestinal microflora 
(R. E. Ley et al., 2005). The closest named organisms belong to the Genus 
Anaeroplasma (highlighted in blue).
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Figure 1.2-B: Neighborhood joining, phylogenetic sub-tree constructed from BLAST ‘hits’ with the 
submitted DM1 ‘consensus’ sequence. As this sequence is virtually identical to the ‘consensus’ 
sequence from (Kubs & Musgrave, 2007) report, due to the novel nature of the DM1 ‘consensus’ 
sequence it is of no surprise that this tree places the it in its own branch
Figure 1.2-C: Neighbourhood joining, phylogenetic tree constructed from BLAST ‘hits’, which had a 
maximum sequence difference of 0.05 with the submitted DM1 ‘consensus’ sequence (Iclj30579, 
highlighted in yellow). This tree shows the DM1 ‘consensus’ sequence having high homology with 
uncultured bacterial clones isolated from the human GI tract.
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These results are interesting as these ‘hits’ come from the aforementioned studies that 
suggest that obesity is associated with the functionality of the gut microflora (see 
1.1.4.1). The ratio of Firmicutes to Bacteriodetes has being found to correlate to the 
efficiency in which energy is harvested from ingested food and are converted to fat, 
with a higher proportion of Firmicutes increasing this efficiency (Backhed et al., 
2005; R. E. Ley et al., 2005; R. E.  Ley et al., 2006). As the novel anaerobic 
Mollicute-like species identified by (Kubs & Musgrave, 2007) belongs to the 
bacterial division of the Firmicutes, and were present in all of the tissue samples and 
fecal samples tested, it is not only possible that they constitute an important 
component of the microbial flora of the human gastrointestinal tract, but could also 
have functionality associated with obesity.
1.3 Mollicutes
A noteworthy observation is that Mollicutes or ‘Mycoplasmas’ are generally 
pathogenic in nature, it is therefore interesting that these preliminary studies have 
revealed the presence of these organisms with the human gastrointestinal tract and 
suggest that they are there in large quantities (Kubs & Musgrave, 2007). Below a 
summary is given concerning the characteristics of the Mollicutes and the methods 
employed in identifying them.
1.3.1 Overview
The smallest known self-replicating cellular organisms, distinguished from other 
bacteria by their lack of cell walls,  the Genus of Mycoplasma (myces, a fungus; 
plasma, a form, in Latin), has had its title, by and large, accepted as the epithet for all 
the microorganisms belonging to its own bacterial class: the Mollicutes (mollis, soft; 
cutis, skin, in Latin). Hence this ‘trivial’ term is interchanged  with ‘Mollicutes’ 
throughout the literature in which it is present (S. Razin et al., 1998).
Prevalent throughout the natural world, Mollicutes have been established as parasitic 
or commensal organisms residing within plants, arthropods, fish, reptiles, mammals 
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and humans (S. Razin, 1992). Attributable to this noted parasitic nature it is of no 
surprise that many have being implicated or identified as the causative pathogenic 
agents of numerous diseases. Mollicutes are considered to be both host and tissue 
specific, this fastidious nature is mirrored in the difficulties arising during isolation 
and culturing procedures. 
Exhibited by their requirements of complex media in order to grow, Mollicutes are
dependant on their hosts for the provision of essential nutrients. This dependency is 
directly related to the absence of genes necessary for functional and structural 
biochemical pathways and as a result Mollicutes possess limited metabolic abilities 
and small genomes. Their known genomes range in size from 577Kbp (Mycoplasma
genitalium) to 2220Kbp (Spiroplasma ixodetis) and it would seem as a general rule 
that phylogenetically ‘earlier’ Mollicutes have larger genomes than those that come 
‘later’, this is compatible with the view that Mollicutes have undergone ‘reductive 
evolution’ (Bove, 1993; S. Razin et al., 1998; Woese, 1987). 
Mollicutes are suggested to have regressively evolved (i.e. reduction in genome size) 
from the low G+C, Gram positive, Clostridium-Streptococcus-Lactobacillus
phylogenetic branch of the eubacteria (Pettersson, Tully, Bolske, & Johansson, 2001). 
Akin to their ancestors, they possess circular DNA genomes with low G+C content, 
which usually ranges from 24-33 mol% G+C (S. Razin et al., 1998). Over time, 
phenotypes displaying decreased numbers of rRNA operons and tRNA genes, the 
aforementioned lack of a cell wall, size, fastidious growth, and limited metabolic 
activities began to arise and are considered results of reductive evolution (Bove, 
1993). Owing to this, Mollicutes have become of great interest with respect to the 
‘minimal cell’ concept (Maniloff, 1996), of which ‘the goal has been to prove the 
dogma of the completeness of molecular biology, that is, that the logic of life is finite, 
relatively simple and subject to full exploration whereby the minimal amount of 
essential genes required for life can be determined’ (S. Razin, 1997).
Consistent with their low G+C and therefore high A+T biased genomic evolution; 
synonymous codons containing A+T have being favoured in the ‘later’ Mollicutes. 
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Such A+T selective pressures are seen in the reassignment of the UGA ‘stop’ codon 
to a ‘tryptophan’ codon (traditionally UGG) (S. Razin et al., 1998). 
The number of required genes are further decreased through the lack of cell walls and 
the absence of intracytoplasmic membranes, which coincidently leaves Mollicutes
having only one type of membrane, the plasma membrane (Rottem & Kahane, 1993). 
Located on the cell surface, lipoproteins constitute over two-thirds of the plasma 
membrane, a proportion that is considerably higher that those seen in other bacteria. 
Being antigenic in nature and found to be highly variable, it is of no revelation that 
these lipoproteins play an integral role in colonising and maintaining the host-
Mollicute relationship (Sirand-Pugnet et al., 2007). The other third of the plasma 
membrane is composed of lipids, but despite this, most Mollicutes are partially or 
totally incapable of carrying out the necessary fatty acid synthesis. This has resulted 
in the reliance upon their host organisms for the supply of required lipids and 
cholesterol (a unique component of some Mollicutes) in order to facilitate their own 
growth (S. Razin et al., 1998). 
The dependency on other organisms in-situ by Mollicutes are typified in-vitro by the 
complex media that are called upon when utilising culture based techniques for 
Mollicute identification. Fortunately, it would seem that such time-consuming 
burdens have been relieved somewhat by the application of molecular techniques. But 
despite this progress, it is generally accepted, that only the ‘tip of the iceberg’ has 
being revealed in respect to the number of Mollicutes identified and the actual 
number present in the environment.
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Table 1.3-A: Properties Distinguishing Mollicutes from Other Bacteria (adapted from (Shmuel Razin, 
1995)).
1.3.2 Taxonomy and Phylogeny
‘Prior to the era of rapid and inexpensive sequencing, the outlook for developing a 
comprehensive and usable taxonomy of the prokaryotes was bleak’ (Lilburn & 
Garrity, 2004). Although numerous Mollicute species have had their entire genomes 
sequenced, we are some distance from being able to form what could be considered, 
highly accurate taxonomic and phylogenetic descriptions of this Class, or even the 
Domain of Bacteria itself. Taking this into account, most Mollicute taxonomy has had 
to be constructed using a combination of phenotypic characteristics and phylogenetic 
information from fractional genomic sequences, primarily those from ribosomal 
genes (S. Razin et al., 1998).
1.3.2.1 Phylogenetic Markers
Their presence and consistent functionality throughout the three Domains of life 
(Bacteria, Archaea and Eucarya makes the complex and modular protein
Properties Distinguishing Mollicutes from Other Bacteria
Property Mollicutes Other Bacteria
Cell wall Absent Present
Plasma membrane Cholesterol present in most 
species
Cholesterol absent
Genome size 577-2220 Kbps 1450- >6000Kbp
G + C content of genome 23-41 mol% 25-75 mol%
No. of rRNA operons 1-3 1-10
5S rRNA length 104-113 nucleotides >114 nucleotides
No. of tRNA genes 30 (M. capricolum) 51 (B. subtilis)
33 (M. pneumoniae) 78 (E. coli)





RNA polymerase Resistant to rifampicin Rifampicin sensitive
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synthesising machinery, ideal candidates for phylogenetic analysis. The prokaryotic 
ribosomal RNA’s (5S, 16S and 23S) contain highly conserved regions of sequence, 
for this reason, comparing these sequences by alignment and determining the degree 
of similarity between them, enable evolutionary relationships to be established. 
Higher similarities are indicative of closer evolutionary relationships and vice versa. 
Variable regions within these large ribosomal gene sequences are employed as 
evolutionary chronometers, measuring the evolutionary distance between two 
organisms (Madigan, Martinko, & Parker, 2003). 
16S rRNA is the most widely used of the ribosomal phylogenetic markers; 16S rDNA 
sequence analysis of the prokaryotes has shown that the Mollicutes are taxonomically 
positioned within the bacterial Division of the Firmicutes. It has also revealed that the 
Mollicutes’ class has revealed over 200 species placed into the following Genera: 
Mycoplasma, Eperythrozoon, Haemobrtonella, Ureaplasma, Entomoplasma, 
Mesoplasma,  Spiroplasma, Acholeplasma, Phytoplasma Anaeroplasma and
Asteroleplasma; all of which belong to the Orders: Mycoplasmatales, 
Entomoplasmatales, Acholeplasmatales, and Anaeroplasmatales (Garrity, Bell, & 
Lilburn, 2004). The presence of species of uncertain taxonomic positioning has 
eventuated in the creation of the additional Order: Incertae sedisi which contains the 
proposed Genera: Erysiperothrix, Bulleidia, Holdemania and Solobacteria (Garrity 
et al., 2004) (see Table 1.2-A.).  
16S rDNA sequence data is a prerequisite when describing a new species for the
‘Mollicutes Taxonomy Committee’, naturally, new insights and developments in 
molecular techniques has invariably led to the preference of complementary data
accompanying that of the 16S rDNA sequence (S. Razin et al., 1998). Investigated 
complementary rDNA data, such as sequencing and targeting of 5S (Woese, 
Maniloff, & Zablen, 1980), tRNA (Stakenborg et al., 2005) and the 16S-23S rRNA 
intergenic transcribed spacer (ITS) regions (Volokhov et al., 2006; H. Wang, Kong, 
Jelfs, James, & Gilbert, 2004) have proved to be practical in the detection and
characterisation of many Mollicutes (Volokhov et al., 2006). With access to these 
potential targets, methods such as microarray and reverse line blot hybridisations and 
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differing polymerase chain reaction (PCR) analytical techniques, have successfully 
established them as useable distinguishing phylogenetic markers.
Other complementary markers that are non-rDNA in origin that have been applied to 
date include the elongation factor EF-Tu (tuf) gene and the heat shock protein (hsp70) 
gene, not unlike the previously discussed rDNA genes, these genes display regions of 
conserved sequence and hence are suitable candidates for constructing phylogenetic 
relationships (S. Razin et al., 1998). 
1.3.2.2 Phenotypic Markers
As emphasised earlier, isolation of Mollicutes is difficult, time-consuming and labour 
intensive, if possible at all. In spite of these major limiting factors, there are a number 
of phenotypic markers present that aid in the classification of isolated members of the 
Mollicute class. Some markers are taken from a proteomic approach, i.e. study of 
functional proteins (i.e. enzymes), which ultimately influence the cell’s nutritional 
requirements (e.g. cholesterol, arginine, urea) and the eventuating metabolic waste 
products. The variable antigenic membrane surface of the Mollicutes provides a 
unique structure for serological based identification, the membrane also harbors polar 
lipid and fatty acids which have their own profiles (S. Razin et al., 1998; Worliczek, 
Kampfer, Rosengarten, Tindall, & Busse, 2007).
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1.4 Hypothesis and Aims
In light of the acquired data from the preliminary study carried out by (Kubs & 
Musgrave, 2007), we hypothesise that these novel Firmicutes are members of a new 
Mollicute Genus related to Anaeroplasma, are widely distributed throughout the 
human G.I tract and are a significant component of the total microbiota. 
Our aim is to take a molecular biological approach and use the newly deposited 
human sequences (R. E. Ley et al., 2005; R. E.  Ley et al., 2006) and others that also 
relate to the DM1 consensus sequence to design and create primers that would 
amplify and characterise full-length versions of these Mollicute-like sequences from 
our human gastrointestinal samples.
With the increasing importance of finding ways to combat obesity in the western 
world, this research could be seen as an opportunity to further understand the 
microflora component of this diverse syndrome.  Furthermore, research into the roles
of Mollicute species in both the micro-organism G.I population dynamics and human 
health could be gained, assisting ultimately in finding medical solutions to the disease 
and ill health that they are responsible for, or suspected of causing in humans. 
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Chapter 2: Expanding the 109F/927R Amplicon
2.1 Introduction
A number of methods that are common place in molecular biology, such as 
sequencing and PCR require ‘primers’ in order to function. Primers are generally 
short, chemically synthesized single stranded oligonucleotides, with an approximate 
length of twenty bases. They are designed to hybridise to a region of target DNA, 
which is then copied by DNA polymerase. Our aim was to expand the length of the 
~830bp ‘known’ 16S rRNA gene sequences (using the DM1 Consensus sequence as a 
representative) determined in preliminary studies using the primers: 109F/927R, 
primers were designed and tested with this objective in mind.
2.2 Materials and Methods
2.2.1 Primer Design
2.2.1.1 Ribosomal Database Project 10
Relevant and related sequences were obtained from the Ribosomal Database Project 
10 (RDP) website (http://rdp.cme.msu.edu/). Multiple ‘out-group’ sequences were 
also selected, these ‘out-groups’ were not related to the relevant sequences and were 
used to assist in determining unique regions of sequence belonging to all of the 
relevant sequences. After these regions were determined the ‘out-groups’ were 
removed to increase the ease with which the alignment could be read and the primers 
designed.
2.2.1.2 ClustalW2
Sequences obtained from the RDP website were collectively submitted into the 
ClustalW2 sequence alignment program located on the European Bioinformatics 
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Institute (EBI) website (http://www.ebi.ac.uk/Tools/clustalw2/index.html). The 
alignment result was printed and manually checked, regions of unique sequence 
present in the relevant sequences and absent in ‘out-group’ sequences were
subsequently highlighted and considered as potential primer designing sites.
2.2.1.3 Forward Primer Designs.
Potential forward primers ran 5’-3’ within the target sequences. Potential forward 
primers design sites were narrowed down and selected with respect to: their position 
in the sequences (5’ end targeted), the number of unique nucleotides present within 
close proximity of one another (primers are generally ≤20bp) and the number of 
unique nucleotides present at the 3’ end of the potential primer region, to promote 
primer specificity and stability. All potential forward primers were tested for viability 
using Primer3.
2.2.1.4 Reverse Primer Designs
Potential reverse primers were reverse and complementary to their potential binding 
sites within the target sequence. Potential reverse primer designing sites were 
narrowed down and selected with respect to: their position in the sequences (3’ end 
targeted), the number of unique nucleotides present within close proximity of one 
another (primers are generally ≤20bp) and the number of unique nucleotides present 
at the 5’ end of the potential primer target region, to promote primer specificity and 
stability. All potential reverse primers were tested for viability using Primer3.
2.2.2 Theoretical Testing of Designed Primers
2.2.2.1 Primer3
The viability and the compatibility of potential primers with existing or other 
potential primers was determined using the Primer3 Input 0.4.0 program located at 
http://frodo.wi.mit.edu/. This program required the input of a relevant target 
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sequence; primer/s were then submitted, and analysed with the target sequence. If the 
primer/s were viable they were ordered from Sigma-Aldrich® 
(http://www.sigmaaldrich.com/life-science/custom-oligos/custom-dna.html) for use 
in subsequent PCR reactions.
2.2.2.2 BLAST
In order to deduce whether primers would be able to target the desired 16S rRNA 
sequences, they were submitted to the BLAST tool located on the National Center for 
Biotechnology Information (NCBI) website (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
The parameters for BLAST were: Nucleotide BLAST; Non-redundant Database 
(Nucleotide Collection (nr/nt); Megablast (optimised for highly similar sequences).
2.2.2.3 Classifier
In order to deduce whether primers would be able to target the desired 16S rRNA 
sequences, they were submitted to the Classifier tool located on the Ribosomal 
Database Project (RDP) website (http://rdp.cme.msu.edu/classifier/classifier.jsp). The 
classification algorithm that aligned 16S rRNA sequences was designed by (Q. 
Wang, Garrity, Tiedje, & Cole, 2007)
2.2.3 Practical Testing of Designed Primers
2.2.3.1 DNA Extraction and Isolation
2.2.3.1.A Samples
Longitudinal samples representing a transect of the human gastrointestinal 
tract, were obtained from patients undergoing surgery of such nature at the 
Hopital Europeen Georges Pompidou, Paris, France, courtesy of Dr Benjamin 
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Wyplosz. These were later processed by Dr David Musgrave either at The 
Institut Pasteur Paris, France or The University of Waikato, Hamilton, New 
Zealand.
2.2.3.1.B DNA Extraction and Isolation
Total DNA was extracted and isolated from samples for use in subsequent 
experiments using an adapted Benzyl alcohol-guanidine hydrochloride 
organic extraction method (Fredricks & Relman, 1998).
Cells were lysed on the surface of the sample by the addition and mixing of 
equal quantities of lysis buffer (1mL of buffer to each 1g of sample) (5.0M 
guanidine hydrochloride, 100mM Tris pH 8.0 in Milli-Q® (M.Q.), deionised
water (>18 MΩ resistance)) with the sample. After 5mins shaking in a cold 
room (4°C), 0.4mL of MQ water was added to the tube, followed by 0.8mL of 
99% Benzyl Alcohol, after which the tube was centrifuged at 7000g for 
5mins. 0.4mLs of the resulting aqueous supernatant was removed by pipette 
and placed into a new tube, where the DNA was precipitated by the addition 
of 1/9 volume of 3.0M sodium acetate pH5.2 and an equal volume of 
isopropanol and incubated at room temperature for 5mins; the tube was then
centrifuged at 16,000g for 15mins, the supernatant removed, and the DNA 
pellet air dried for 2h at room temperature. The pellet was re-suspended in 
200µL of TE 10/0.1, the DNA pellet then had an equal amount of Phenol 
added to denature and remove any proteins that were present. The tube and its 
contents were mixed for 10mins, placed on ice for another 10mins and spun at 
5000g for 2mins. If the aqueous phase was cloudy the phenol wash was 
repeated until clear.
The supernatant was transferred to a new tube with an equal volume of 
phenol/chloroform/isoamyl alcohol (P/C/IAA) solution (25:24:1); the phenol 
denatured any proteins; the chloroform denatured proteins and also stabilised
the organic/aqueous boundary while the isoamyl alcohol assisted in separating
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the two phases to decrease any foaming. After addition of the (P/C/IAA) 
solution mixing was carried out, the tube was then placed on ice and spun, and 
the aqueous phase removed and transferred to a new tube. The (P/C/IAA) 
treatment was then repeated.
Upon completion of the second (P/C/IAA) treatment the aqueous phase was 
treated solely with 200µL of chloroform, and again, mixed, placed on ice, 
spun, with the aqueous phase removed and transferred to a new tube. The 
DNA was again precipitated out of the solution by addition of 1/9 volume of 
3.0M sodium acetate pH5.2 and an equal volume of isopropanol, incubated, 
spun and air dried prior to re-suspension in 0.1mL TE 10/0.1. All processed 
samples were labeled and stored at ≤ -20°C.
2.2.3.2 Polymerase Chain Reaction
The designed primers were tested practically using the Polymerase Chain Reaction 
(PCR). PCR is a fast, efficient and economically viable method employed in the 
amplification of specific regions of DNA that has become fundamental in molecular 
biology.  It utilises the specificity of primers designed to select a target sequence and 
the heat-stable properties of some DNA polymerases (e.g. Taq polymerase, isolated 
from Thermus aquaticus ) to replicate these sequences at the high temperatures 
required for PCR (Hartwell et al., 2004). 
2.2.3.2.A Primers
Dry primer stocks were ordered and received from Sigma-Aldrich®. They 
were re-suspended in DNA-free Tris-EDTA (10/1) to have a final 
concentration of 1mM. This concentration was attained by the addition of an 
equivalent number of µL of TE (10/1) to the number of nanomoles received 
for each primer; these values were stated in the delivery’s supplementary 
‘Oligonucleotide Data Sheet’. From these 1mM stocks, 100µM and 10µM 
solutions were made by re-suspension in DNA free TE (10/0.1) and water 
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respectively. All primers were stored at ≤ -20°C, with the 10µM solutions 
used in all subsequent PCR reactions, at final concentrations of 0.4µM.
2.2.3.2.B dNTPs
While placed on ice, 20µL was removed from 100mM stocks of each of the 
four dNTPs. These were then mixed carefully in an Eppendorf tube and 
followed by the addition of 120uL 10mM Tris buffer at pH8, giving a total 
volume of 200µL at a concentration of 10mM. 20µL aliquots were placed into 
PCR tubes, which were labeled and placed into a larger 15mL falcon tube, 
which was labeled and stored at ≤ -20°C for use in subsequent PCR reactions, 
at final concentrations of 40µM.
2.2.3.2.C DNA Free Water
Milli-Q®, deionised water (>18 MΩ resistance) was filtered through an 
Advantec Cellulose Acetate 0.20µM Syringe Filter Unit into sterile Petri 
dishes, which were then exposed to U.V light for 1hr, before undergoing a 
final filtration, before being aliquoted into labeled 1.5mL tubes stored at ≤ -
20°C.
2.2.3.2.D DNA Free TE Solutions 
Autoclaved solutions of Tris pH 8 (1.0M) and EDTA (0.5M) were mixed with 
Milli-Q®, deionised water (>18 MΩ resistance) to produce two solutions with 
final compositions of TE 10/1.0 and 10/0.1. These were then filtered, exposed 
to U.V light and filtered again before being aliquoted into labeled 1.5mL 
tubes and stored at ≤ -20°C as done with the DNA free water.
-31-
2.2.3.2.E 10X PCR Reaction Buffer
Invitrogen™ 10X PCR Reaction Buffer was stored at ≤ -20°C and used in all 
subsequent PCR reactions to give a final concentration of 1X.
2.2.3.2.F Magnesium Chloride
Invitrogen™ MgCl2 50mM was stored at ≤ -20°C and used in all subsequent 
PCR reactions at a final concentration of 2.5mM.
2.2.3.2.G Taq Polymerase
Invitrogen™ Platinum Taq DNA Polymerase 5U/µL was stored at ≤ -20°C 
and used in all subsequent PCR reactions at a final concentration of 
0.5U/25µl.
100µL of PCR reaction mix (required for four 25µL reactions) contained:
10µL of 10X PCR reaction buffer  (FC 1X)
5µL of 50mM MgCl2 (FC 2.5mM)
0.4µL TAQ 5U/µl (FC 0.5U/25µL)
4µL of each 10µM primer (FC 0.4µM)
0.4µL 10mM dNTPs (FC 40µM)
80.2 µL of sterile DNA free water to bring volume up to100ul
2.2.3.2.H PCR protocols
Except for gradient PCRs, all PCRs were run in the MJ Research Inc™ PTC-





55°C 30sec          30 Cycles
72°C 1min
72°C 7min
Thermal gradient PCRs were run in the MJ Research Inc™ PTC-200™ Peltier 
Thermal Cycler using the custom designed protocol: DMGRAD.
DMGRAD: 95°C 3min
95°C 30sec




Gel electrophoresis is a method used to separate, purify and identify fragments of 
DNA depending upon their individual size, weight and chemical composition. 
Separation of these fragments is achieved with the application of an electrical current 
across a cross-linking, porous gel matrix. One cross linker, agarose, is capable of 
separating a broad range of DNA fragments, with lower concentrations (e.g. 0.1-0.2% 
w/v) creating larger pores in the gel and resolving larger fragments and vice-versa. 
Separation of DNA fragments in this work was done so following the ‘Agarose gel 
electrophoresis’ method outlined in (Sambrook & Russell, 2001). 
2.2.3.3.A Gel Preparation
All gels were cast using ‘Ultrapure™’ agarose powder.
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Tris-borate-EDTA (TBE) gels
TBE gels were made using 10x Tris-borate-EDTA (TBE) pH8.0 buffer, 
6.3mM ethidium bromide and double distilled water. Final composition of the 
TBE gels were 1.0% agarose, 1x TBE (90mM Tris–borate, 2mM EDTA) 
pH8.0 buffer and 0.03mM ethidium bromide.
Tris-acetate-EDTA (TAE) gels
TAE gels were made using:  50x TAE pH8.0 buffer, 6.3mM ethidium 
bromide and double distilled water. Final composition of the TAE gels were 
0.9% agarose, 1x TAE (40mM Tris-acetate, 1mM EDTA) pH8.0 buffer and 
0.03mM ethidium bromide.
2.2.3.3.B Sample Preparation
DNA that was to undergo electrophoresis from extractions, PCRs, 
precipitations, had 1.3x or 6x Gel-loading buffer concentrations (0.25% 
bromophenol blue, 0.25% xylene cyanol FF, 15% Ficoll in TE 10/1; method 
modified from (Sambrook & Russell, 2001), to replace H20 with TE 10/1) 
added to and mixed with, giving a final buffer concentration of 1x.
2.2.3.3.C Electrophoresis 
Electrophoresis of gels was carried out using an Owl Lightning Volt (Model 
OSP-250L) power supply. Small gels were electrophoresed in an Owl 
Separation System (Model: B1A) at 100V (constant voltage) for 1hr, while 
larger gels were electrophoresed in a Gibco/BRL Gel Electrophoresis 
Apparatus (Model: Horizon 11.4) at 110V (constant voltage) for 1hr. All gel 
results were illuminated with ultraviolet light (U.V), light and photographed; 




The desired amplicons for the two primer sets 1AF/927R or 927R NEW and 109F or 
109F NEW/1391R are pictured in Figure 2.3-A.
Primer Set Targets for Extending the Known Sequence
Known Sequence with Extended 5’ end Region (~920bp):





Known Sequence with Extended 3’ end Region (~1280bp):
109F/ 109F NEW 1391R
[-----------------------------------------------------------------------------------]
Figure 2.3-A: Depiction of primer set targets and their theoretical or known amplicons.
2.3.1 1 Anaeroplasma Forward (1AF), 927 Reverse (927R) and 
927R NEW Primer Design
With the intention of extending the 5’ end region of the known 16S sequence, 1AF 
was designed as a forward primer to target sequences which belonged to members of 
the bacterial genus: Anaeroplasma. This primer was used in conjunction with the 
specific 927R reverse primer, which was used in preliminary analysis to amplify the 
Mollicute-like ‘known’ sequence, and the modified version of 927R, 927R NEW
which was designed to be more specific to sequences similar to the DM1 consensus 
sequence.
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2.3.2 1391R Reverse, 109 Forward (109F) and 109F NEW 
Primer Design
With the intention of extending the 3’ end region of the known 16S sequence, 1391R 
was a reverse primer designed for this purpose. This primer was used in conjunction 
with the specific 109F forward primer, which was used in preliminary analysis to 
amplify the Mollicute-like known sequence, and the modified version of 109F, 109F 
NEW, which was designed to be more specific to sequences similar to the DM1 
consensus sequence.
2.3.3  Sequences Obtained from the Ribosomal Database 
Project 10 and NCBI Databases and Aligned with 
ClustalW2
Below Figures 2.3B-2.3E display ClustalW2 alignments of the 16S rRNA gene 
sequences belonging to species of the Anaeroplasma genus, these were downloaded 
from the RDP10 website. The other sequences in the alignment belong to uncultured 
species with similar sequences to that of the DM1 consensus sequence, all of which 
were found in the NCBI database. The sequence differences are highlighted in red 
and the relevant primers positioned above their target region within the alignment.
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Figure 2.3-B: Region of ClustalW2 result used for the design of the forward primer 1AF.
             Eckburg 8F                  AGAGTTTGATCCT-GGCTCAG
1AF                        GAGAGTTTGATCMT-GGCTCAS
EU006469          ---------------------AT-GGCTCAGGATTAACGCTGGCGGCGTGCCTAATACAT 38
EU006334          ---------------------AT-GGCTCAGGATTAACGC-GGCGGCGTGCCTAATACAT 37
EF406813          ---------TAGAGTTTGATCAT-GGCTCAGGATTAACGCTGGCGGCGTGCCTAATACAT 50
EU006409          --------------------------------------GCTGGCGGCGTGCCTAATACAT 22
EF604794          ---------------------CT-GGCTCACGATTTG-GCTGGCGGCGTGCCTAATACAT 37
A.abactoclasticum --NNTTATGGAGAGTTTGATCCT-GGCTCAGGATTAACGCTGGCGGCGTGCCTAATACAT 57
A.varium          ---NTTTTGGAGAGTTTGATCCT-GGCTCAGGATTAACGCTGGCGGCGTGCCTAATACAT 56
EF445276          -----------GAGTTTGATCAT-GGCTCAGGATTAACGCTGGCGGCATGCCTAATACAT 48
A.laidlawii       -TTTATATGGAGAGTTTGATCCT-GGCTCAGGATGAACGCTGGCGGCGTGCCTAATACAT 58
A.vituli          ----------AGAGTTTGATCCTTGGTTCAGGATGAACGCTGGCGGCGTGCCTAATACAT 50
DQ797049          ----------AGAGTTTGATCCT-GGCTCAGGATGAACGCTGGCGGCGTGCCTAATACAT 49
E.dolichum        --NCAAATGGAGAGTTTGATCCT-GGCTCAGGATGAACGCTGGCGGCATGCCTAATACAT 57
A.agalactiae      NNNTTTTTCGAGAGTTTGATCCT-GGCTCAGGATGAACGCTGGCTGTGTGCCTAATACAT 59
M.pneumoniae      -NNTTTTCTGAGAGTTTGATCCT-GGCTCAGGATTAACGCTGGCGGCATGCCTAATACAT 58
                                                     ** *** *  ************
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Figure 2.3-C: Region of ClustalW2 result used for the design of the forward primer 109F/109F NEW
             109F                  ACGGCTSAGTAACRCGTRG
             109F NEW             CGAACGGRTRAGTAAYACRTAG
EU006469          GGCGAACGGGTAAGTAATACATAGGTAACCTACCCTTAAGACGAGGATAGCCATTGGAAA 133
EU006334          GGCGAACGGATGAGTAATACGTAGGTAACCTACCCTTAAGACGAGGATAGCCATTGGAAA 132
EF406813          GGCGAACGGGTGAGTAATACATAGGTAACCTACCCTTAAGACGAGGATAGCCATTGGAAA 145
EU006409          GGCGAACGGGTGAGTAATACATAGGTAACCTACCCTTAAGACGAGGATAGCCATTGGAAA 117
EF604794          GGCGAACGGGTGAGTAATACATAGGTAACCTACCCTTAAGACGAGGATAGCCATTGGAAA 132
A.abactoclasticum GGCGAACGGGTGAGTAACACGTAGGCAACCTGTCTTTAAGACGAGGATAACCGTTGGAAA 149
A.varium          GGCGAACGGGTGAGTAACACGTAGGTAACCTGTCTTTAAGACGAGGATAACCGNTGGAAA 141
EF445276          GGCGAACGGGTGAGTAATACGTAGGTAACCTACCTTTAGGACGAGGATAACCTTTGGAAA 137
A.laidlawii       GGCGAACGGGTGAGTAACACGTAGATAACCTACCTTTAACTCGAGGATAACTCCGGGAAA 151
A.vituli          GGCGAACGGGTGAGTAACACGTAGGTAACTTACCTCTAAGACGAGGATAACGACTGGAAA 139
DQ797049          GGCGAACGGGTGAGTAACACGTAGGTAATCTACCCTTAAGACGAGGATACCGCTTGGAAA 140
E.dolichum        GGCGAACGGGTGAGTAACACGTAGATAACCTGCCCATGTGCCCGGGATAACTGCTGGAAA 167
A.agalactiae      GGCGAATGGGTGAGTAACACGTACTCAACGTACCTTTTAGATTGGGATAGCGGATGGAAA 150
M.pneumoniae      GGCGAACGGGTGAGTAACACGTATCCAATCTACCTTATAATGGGGGATAACTAGTTGAAA 149
              ****** ** * ***** ** **   **  *  *          ***** *     ****
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Figure 2.3-D: Region of ClustalW2 result used for the design of the Reverse Primers 927R/927.
          
             927R Reverse Complement:                 --GAAACTTAAA-GGAATTGACGGG
             927R NEW Reverse Complement:             -TMAAACTWAAA-GGAYRTGACGGG
EU006469          CCTGAGTAGTACGTACGCAAGTATGNAACTAAAA-GGAATGACGGGGAGCCCGCACAAGC 886
EU006334          CCTGAGTAGTTCGTCCGCAAGTATTAAACTTAAA-GGAACTGACGGGAGTTCGCACAAGC 885
EF406813          CCTGAGTAGTACGTACGCAAGTATGAAACTTAAA-GGAATTGACGGGAGCCCGCACAAGC 899
EU006409          CCTGAGTAGTACGTACGCAAGTATGAAACTTAAA-GGAATTGACGGGAGCCCGCACAAGC 871
EF604794          CCTGAGTAGTACGTACGCAAGTATGAAACTTAAA-GGAATCGACGGGAGCCCGCACGAGC 886
A.abactoclasticum CCTGAGTAGTACGTACGCAAGTATGAAACTTAAA-GGAATTGACGGGAGCCNGCACAAGC 909
A.varium          CCTGAGTAGTACGTACGCAAGTATGAAACTTAAA-GGAATTGACGGGAGCCNGCACAAGC 897
EF445276          CCTGAGTAATACGTACGCAAGTATGAAACTTAAA-GGAGTTGACGGGAGCCCGCACAAGC 889
A.laidlawii       CCTGAGTAGTACGTACGCAAGTATGAAACTCAAA-GGAATTGACGGGACCCCGCACAAGC 906
A.vituli          CCTGAGTAGTACGTACGCAAGTATGAAACTCAAA-GGAATTGACGGGACCCCGCACAAGC 918
DQ797049          CCTGAGTAGTACGTACGCAAGTATGAAACTTAAA-GGAATTGACGGGATCCCGCACAAGC 894
E.dolichum        CCTGGGGAGTATGCACGCAAGTGTGAAACTCAAA-GGAATTGACGGGNGCCNGCACAAGC 944
A.agalactiae      CCTGAGTAGTACGTTCGCAAGAATAAAACTTAAA-GGAATTGACGGGGATNCGCACAAGC 929
M.pneumoniae      CCTGGGTAGTACATTCGCAAGAATGAAACTCAAACGGAATTGACGGGGACCCGCACAAGT 936
             **** * * *     ******  *  **** *** ***      ***     **** **
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Figure 2.3-E: Region of ClustalW2 result used for the design of the Reverse Primer 1391R.
1391R: GTTTGACGGGCGGTGTGTA















*   ************** ****  *** ** ********* ***
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2.3.4 Blast Results for Submitted Primers
Figure 2.3-F: BLAST result for the 1AF primer.
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Figure 2.3-G: BLAST result for 109F primer.
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Figure 2.3-H: BLAST result for primer 927R
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Figure 2.3-I: BLAST result for the primer 1391R
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2.3.5 Primer3 Results
The Figures shown below (Figures 2.3-J, 2.3-K) are the Primer3 results for the 
submitted primer sets: 1AF/927R and109F/1391R with the Anaeroplasma 
abactoclasticum 16S rRNA sequence used as a template. Any redundancy was 
removed from the primer with the appropriate nucleotide featured within the primer, 
as Primer3 did not recognize redundancies. 
Figure 2.3-J: Primer3 result for the, 5’ region extending primer set 1AF/927R.
Primer Start Length tm (ºC) GC% Comp. 3’ Comp.
1AF  (LEFT) 8 21 59.03 52.38 7.00 5.00
927R (RIGHT) 896 22 59.04 40.91 5.00 0.00
SEQUENCE SIZE: 1453
INCLUDED REGION SIZE: 1453
PRODUCT SIZE: 889, PAIR ANY COMPL: 4.00, PAIR 3' COMPL: 1.00
    1 NNTTATGGAGAGTTTGATCCTGGCTCAGGATTAACGCTGGCGGCGTGCCTAATACATGCA
             >>>>>>>>>>>>>>>>>>>>>                                
   61 AGTCGAATGGTAGTAGCAATACAAACCATGGCGAACGGGTGAGTAACACGTAGGCAACCT                                                                
  121 GTCTTTAAGACGAGGATAACCGTTGGAAACGACGGATAATACTGGATAGGACATCACAAA
  181 GGGCATCCTTAGATGTTTAAAGGTTATTATGCCACTTAGAGAGGGGCCTGCGGCGCATTA                                                                  
  241 GCTAGTTGGTGAGATAACAGCCCACCAAGGCGATGATGCGTAGCCGGACTGAGAGGTTGA                                                                 
  301 ACGGCCACAATGGAACTGAGAACGGTCCATACTCCTACGGGAGGCAGCAGTAGGGAATTT                                                                  
  361 TCGGCAATGGGCGCAAGCCTGACCGAGCAACGCCGCGTGAACGAAGAAGTTATTCGTAAT                                                                  
  421 GTAAAGTTCTTTTATCTGGGAAGAAAAAACAAATTGACTGTACCAGATGAATAAGCTCCG                                                                  
  481 GCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGGAGCNAGCGTTATCCGGAATTATT                                                                 
  541 GGGCGTAAAGGGTGCGCAGATGGCACATTAAGTTTCTTGTAAAAATGCTGGGCTCAACCC                                                                  
  601 AGTAGAGCAAGAGATACTGATGAGCTAGAGTACGAGAGAGGCAAGTGGAATTCCATGTGT                                                               
  661 AGCGGTAAAATGCGTAAATATATGGCAGAACACCAGTGGCGAAGGCGGCTTGCTAGCTCG                                                                  
  721 ATACTGACATTGAGGCACGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCC                                                      
  781 ACGCCCTAAACGATGAGTACTAAGTGCTGGGAGGAATCTCGGTGCTGAAGTTAACGCATT                                                                  
  841 AAGTACTCCGCCTGAGTAGTACGTACGCAAGTATGAAACTTAAAGGAATTGACGGGAGCC
                                        <<<<<<<<<<<<<<<<<<<<<<    
  901 NGCACAAGCGGTGGAGCATGTTGTTTAATTCGACGNTACGCGAAGAACCTTACCAGGTCT                                                                  
  961 TGACATCCTCTGCGAAGCTATAGAGATATAGTGGAGGTTAGCAGAGAGACAGGTGGTGCA                                  
 1021 TGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCT                                                                  
 1081 TATATCTAGTTACCATCATTCAGTTGGGGACTCTAGATAGACTGCCATTGATAAAATGGA                        
 1141 GGAAGGTGGGGATGACGTCAAATCATCATGCCCTATATGACCTGGGCTACAAACGTGCTA                                                                  
 1201 CAATGGCTGAAACAAAGAGAAGCGAAGCGGTGACGTGGAGCTAACCTCATAAAAGCAGTC                                                                  
 1261 TCAGTTCGGATTGAAGTCTGCAACTCGACTTCATGAAGTTGGAATCGCTAGTAATCGCGA                                                                  
 1321 ATCAGAATGTCGCGGTGAATACGTTCTCGGGCTTTGTACACACCGCCCGTCAAACCATGA                                                                 
 1381 GAGTTTGTAATACCCGAAGCCGGTGGCCTAACCGCAAGGAAGGAGCCGTCTAAGGTAGGA                                                                  
 1441 CAGATGATTGGGG
                   




Figure 2.3-K: Primer3 result for the, 3’ region extending primer set 109F/1391R.
Primer Start Length tm (ºC) GC% Comp. 3’ Comp.
109F (LEFT) 95 19 53.52 52.63 7.00 2.00
1391R(RIGHT) 1375 19 62.93 57.89 3.00 2.00
SEQUENCE SIZE: 1453
INCLUDED REGION SIZE: 1453
PRODUCT SIZE: 1281, PAIR ANY COMPL: 4.00, PAIR 3' COMPL: 1.00
    1 NNTTATGGAGAGTTTGATCCTGGCTCAGGATTAACGCTGGCGGCGTGCCTAATACATGCA                                                              
   61 AGTCGAATGGTAGTAGCAATACAAACCATGGCGAACGGGTGAGTAACACGTAGGCAACCT
                                        >>>>>>>>>>>>>>>>>>>       
  121 GTCTTTAAGACGAGGATAACCGTTGGAAACGACGGATAATACTGGATAGGACATCACAAA                                                                
  181 GGGCATCCTTAGATGTTTAAAGGTTATTATGCCACTTAGAGAGGGGCCTGCGGCGCATTA                                                               
  241 GCTAGTTGGTGAGATAACAGCCCACCAAGGCGATGATGCGTAGCCGGACTGAGAGGTTGA                                                             
  301 ACGGCCACAATGGAACTGAGAACGGTCCATACTCCTACGGGAGGCAGCAGTAGGGAATTT                                                                
  361 TCGGCAATGGGCGCAAGCCTGACCGAGCAACGCCGCGTGAACGAAGAAGTTATTCGTAAT                                                                  
  421 GTAAAGTTCTTTTATCTGGGAAGAAAAAACAAATTGACTGTACCAGATGAATAAGCTCCG                                                                  
  481 GCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGGAGCNAGCGTTATCCGGAATTATT                                                                 
  541 GGGCGTAAAGGGTGCGCAGATGGCACATTAAGTTTCTTGTAAAAATGCTGGGCTCAACCC                                                                
  601 AGTAGAGCAAGAGATACTGATGAGCTAGAGTACGAGAGAGGCAAGTGGAATTCCATGTGT                                                                  
  661 AGCGGTAAAATGCGTAAATATATGGCAGAACACCAGTGGCGAAGGCGGCTTGCTAGCTCG                                                                
  721 ATACTGACATTGAGGCACGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCC                                                                 
  781 ACGCCCTAAACGATGAGTACTAAGTGCTGGGAGGAATCTCGGTGCTGAAGTTAACGCATT                                                                  
  841 AAGTACTCCGCCTGAGTAGTACGTACGCAAGTATGAAACTTAAAGGAATTGACGGGAGCC                                                                  
  901 NGCACAAGCGGTGGAGCATGTTGTTTAATTCGACGNTACGCGAAGAACCTTACCAGGTCT                                                                  
  961 TGACATCCTCTGCGAAGCTATAGAGATATAGTGGAGGTTAGCAGAGAGACAGGTGGTGCA                                                                  
 1021 TGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCT                                                                  
 1081 TATATCTAGTTACCATCATTCAGTTGGGGACTCTAGATAGACTGCCATTGATAAAATGGA                                                                  
 1141 GGAAGGTGGGGATGACGTCAAATCATCATGCCCTATATGACCTGGGCTACAAACGTGCTA                                                                  
 1201 CAATGGCTGAAACAAAGAGAAGCGAAGCGGTGACGTGGAGCTAACCTCATAAAAGCAGTC                                                                
 1261 TCAGTTCGGATTGAAGTCTGCAACTCGACTTCATGAAGTTGGAATCGCTAGTAATCGCGA                                                              
 1321 ATCAGAATGTCGCGGTGAATACGTTCTCGGGCTTTGTACACACCGCCCGTCAAACCATGA
                                          <<<<<<<<<<<<<<<<<<<     
 1381 GAGTTTGTAATACCCGAAGCCGGTGGCCTAACCGCAAGGAAGGAGCCGTCTAAGGTAGGA                                                    
 1441 CAGATGATTGGGG
                   




2.3.6 PCR Results for Primer Sets 
The Figure below (Figure 2.3-L) depicts the PCR results for all of the potential 
primer sets that were used in PCR reactions that contained template DNA from the
human gastrointestinal mucosal surface sample DM20.
   A   1   2   3  4   5   6   7   8   9  10  B
Figure 2.3-L: Small TBE gel depicting PCR results. A, 100kb ladder (bright band at 600bp); 1, 
Positive control: Mucosal surface sample DNA template DM20 (1:10 dilution) with the primer set 
109F/927R; 2, Negative control: DNA free water with primer set 109F/927R; 3, 1AF/927R; 4, 
Negative control of 3; 5, 109F/1391R; 6, Negative control of 5; 7, 109F NEW/1391R NEW; 8, 
Negative control of 7; 9, 1AF/927R NEW; 10, Negative control of 9; B, 100kb ladder.
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2.4 Discussion 
2.4.1 Theoretical Assessment of Primers
16S rRNA sequences from organisms that were ‘Best Hits’ with DM1 in BLAST, 
along with sequences belonging to members of the Genus Anaeroplasma of which the 
‘Best Hit’ Species Anaeroplasma abactoclasticum belongs, were aligned in 
ClustalW2. The ClustalW2 results (Figures: 2.3-B to 2.3-E) depict the intended 
primer target region within the submitted sequences, with any variations amongst
them highlighted in red. Redundancy was applied to the primers (where necessary) to 
accommodate the aforementioned sequence variations, although, it can be observed
that some of these were not taken into consideration, these were rational decisions, 
based on both the sequence integrity within and surrounding the target region, and the 
frequency of which any polymorphism appeared within the submitted sequences.
In order to establish whether the primers were potentially capable of targeting
relevant 16S rRNA sequences, they were submitted to BLAST (Figures: 2.3-F to 2.3-
I).
The 1AF primer sequence as shown in Figure 2.3-F, had ‘Best Hits’ with a 16S rRNA 
genes from a ‘Pseudomonas aeruginosa strain: Ls4’ and other Pseudomonas species, 
it also had ‘Hits’ with both uncultured and well-known bacterium. These results 
indicated that 1AF was selective towards bacterial 16S rRNA sequences.
The 109F primer sequence as shown in Figure 2.3-G, had a ‘Best Hit’ with the 
‘Uncultured archaeon clone 40H-0S-16 16S ribosomal RNA gene, partial sequence’
and ‘Hits’ with other uncultured archaeon 16S rRNA sequences. These results were 
not-surprising as the 109F primer was initially designed to amplify members of the 
Crenarchaeota from the human gut, yet as discussed in Chapter 1, the 109F/927R 
primer set amplified the Anaeroplasma-like 16S rRNA sequence that is the focus 
point of this thesis because of our inability to amplify crenarchaeal sequences from 
any of the human gut samples (Musgrave personal communication).
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The 927R primer sequence as shown in Figure 2.3-H, had a ‘Best Hit’ with a 16S 
rRNA gene of a ‘Jujube witches’-broom phytoplasma strain Jwb-Henan’, it also had 
‘Hits’ with a Mycoplasma species, and an uncultured bacterium sourced from human 
feces. As Phytoplasmas and Mycoplasmas belong to the Mollicutes, these results 
indicated 927R was selective towards Mollicutes as previous work had shown. 
The 1391R primer sequence as shown in Figure 2.3-I, had a ‘Best Hit’ with a  16S 
rRNA gene of  a ‘Paulownia witches’-broom phytoplasma strain PaWB-Beijing 
subgroup’, it also had ‘Hits’ with other Phytoplasmas and uncultured bacterium from 
environmental samples, including samples from the gut of the Opisthocomus hoazin, 
a leaf-eating bird found in South America (Godoy-Vitorino et al., 2008). These 
results displayed 1391R’s selectivity towards not only bacteria, but also a bacterium 
found in the gut of other species, and also members of the Mollicute class.
The Primer3 results (Figures 2.3-J and 2.3-K) present the theoretical compatibility 
and viability of primer sets. Primer3 determines and takes into consideration a 
primer’s: potential melting point (tm), Guanine/Cytosine content (GC %), self-
complementarity’s (Comp.) and 3’ self-complementarity’s (3’ Comp.); and a primer 
set’s: pair-complementarity’s (Pair Any Compl.) and pair-3’complementarity’s (Pair 
3’ Compl.).
The 1AF/927R primer set was intended to expand the 5’ end region of the known 
sequence, Primer3 determined (Figure 2.3-J) that these primers were compatible with 
each other and the submitted target Anaeroplasma abactoclasticum sequence.
Although the self-complementarity result for the 1AF primer (7.00) is relatively high,
it was considered suitable on the grounds that the 8F primer which it was modeled 
from, is widely used as a universal bacterial primer.
The 109F/1391R primer set was intended to expand the 3’ end region of the known 
sequence, Primer3 determined (Figure 2.3-K) that these primers were compatible 
with each other and the submitted target Anaeroplasma abactoclasticum sequence. 
Although the melting temperature (53.52 ۫C) and self-complementarity (7.00) result for 
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the 109F primer is relatively high, it was considered suitable on the grounds that the 
109F primer was used in preliminary work to amplify the amplicon of interest.
2.4.2 Practical Assessment of Primers
PCRs carried out with candidate primer sets (Figure 2.3-L) gave noteworthy results 
and were seen as promising steps towards extending the known amplicon at both its 
5’ and 3’ ends. 
1AF/927R: showed non specific amplification between ~300-1500bp, there was also 
a brighter band at ~950bp, this is promising as this is located where an amplicon 
containing the targeted known sequence with an extended 5’ region would lie.
109F/1391R: showed a thick band at ~900kb, a position that the PCR amplicon for 
the human mucosal surface sample DM20 template and the primer set 109F/927R 
from preliminary work is expected to be located. This primer set also displayed non-
specific bands between ~100bp and ~1500bp, bands seen at ~1200-1300bp were of 
interest, as this range is where the amplicon with an extended 3’ region would be 
located within the gel.   
109FNEW/1391R: showed a brighter band at ~900kb, a position that the PCR 
amplicon for the human mucosal surface sample DM20 template and the primer set 
109F/927R from preliminary work is expected to be located. This primer set also 
displayed non-specific bands between ~200bp and ~1500bp; bands seen at ~1200-
1300bp were of interest, as this range is where the amplicon with an extended 3’ 
region would be located within the gel.   
1AF/927R NEW: showed non specific amplification between ~200-1500bp, there 
was also a brighter band at ~950bp, this was promising as it is located where an 




Merging the theoretical and practical results, it was deemed viable to determine the 
sequences of the non-specific PCR products and from there, relevant sequences 
would be determined, and it would be seen whether or not any of the sequences were 
extended versions of the known sequence.
It is also worth mentioning that much of the primer validation testing was hindered by 
contamination issues, these were eventually overcome by ordering new primers and 
refreshing all related reagents.
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Chapter 3: Isolation and Sequencing of Amplicons
3.1 Introduction
Despite the absence of a clear-cut PCR product/s from which to work, due to the non-
specific nature of the primers used, it was deemed viable to continue forward with the 
analysis of the potential products that were present, in an effort to extend the already 
known sequence found in preliminary studies. Potential products were selected, 
isolated, cloned, transformed and prepared for sequencing and analysis.
3.2 Materials and Methods
3.2.1 Isolating PCR products
PCR products had to be isolated before they could be used in cloning reactions, 
below is the approach taken.
3.2.1.1 Polymerase Chain Reaction
PCR reactions were carried out following the methodology outlined in 2.2.3.2.
3.2.1.2 Gel Electrophoresis
1µL of each PCR product had 11µL of 1X GLB added to it prior to being run on 
small, TBE, 1% agarose gels at 100V for 1hr, illuminated with UV light and 
photographed with SCION imager.
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3.2.1.3 Bandstabs
Non-specific amplification can lead to the presence of multiple PCR products, in 
order to isolate and further amplify the PCR products of interest from these other
products, band stabs were performed following the method developed by (Copper et 
al. 1992). PCR products were separated in gels, illuminated by UV light; the sought 
after band was then excised by stabbing an Eppendorf  pipette tip perpendicularly into 
the gel, the excised PCR product was re-suspended in 40µL of DNA free water 
overnight at ≤ 4°C, 1µL of supernatant was then used as the template in PCR checks.
3.2.1.4 PEG/MgCl2 PCR Product Precipitation
DNA was precipitated by the addition of the 25µL PCR product to 275µL of the 
14.5% PEG/11mM MgCl2 solution which then underwent mixing and incubation at 
room temperature prior to centrifugation at 12,000 rpm. The remaining PEG solution 
was removed from the precipitated DNA pellet by pipette. The pellet was then 
washed with 300µL, ice cold, 80% ethanol, followed by centrifugation at 12,000rpm 
for 5mins; removal of ethanol by pipette was followed by a further ethanol wash. 
After the final wash the DNA pellet was air dried and resuspended in 10uL TE 10/0.1 
and stored until use in subsequent cloning protocols at ≤ -20°C.
3.2.2 Cloning PCR Products
PCR products were cloned using Topo TA Cloning®, ahead of being sequenced. 
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3.2.2.1 Topo TA Cloning®
Purified PCR products were inserted into a pCR® 2.1-TOPO plasmid vector (F- mcrA 
Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacΧ74 recA1 araD139 Δ(ara-leu) 7697 
galU galK rpsL (StrR) endA1 nupG) (Figure 3.2-A.) following the TOPO® Cloning 
Reaction  outlined in the TOPO TA Cloning® Instruction Manual (Version R), 
Invitrogen ™ (Invitrogen, 2004).
Figure 3.2-A: Map of pCR® 2.1-TOPO and the sequence surrounding the PCR product insertion site
(Invitrogen, 2004)
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3.2.2.2 Transformation of One Shot® TOP10 Competent Cells
The pCR® 2.1-TOPO plasmid was transformed into One Shot® TOP10 Competent 
Cells adhering to the method described in TOPO TA Cloning® Instruction Manual 
(Version R), Invitrogen ™ (Invitrogen, 2004). Transformants were spread and 
incubated overnight at 37°C on selective LB plates containing 50µg/mL kanamycin 
and 40µL of 40mg/mL X-gal in dimethylformamide. A stock solution of X-gal was 
made earlier using a method modified from (Sambrook & Russell, 2001). X-gal was 
dissolved in dimethylformamide to give a final concentration of 40mg/mL. The 
solution was stored in a glass tube, covered with aluminium foil, labelled and stored 
at ≤ -20°C.
3.2.2.3 Selecting Transformants
X-gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) is a galactoside
substrate that is used to determine whether foreign DNA has been inserted into a 
plasmid vector. Recombinant plasmids will contain an inactivated lacZ gene which 
encodes the enzyme: β-galactosidase. This enzyme catabolises β-galactosides into 
galactose and 5-bromo-4-chloro-3-hydroxyindole, the former is used in essential 
metabolic pathways while the latter is oxidised to an insoluble blue product 5'-
dibromo-4,4'-dichloro-indigo. Ergo, blue cell colonies are non-transformed lacZ+, 
while white cell colonies are transformed lacZ- (see Figure 3.2-A). Here, 10 to 20 
white colonies were selected at any one time and transferred to a reference LB/Kan 
plate and incubated overnight at 37°C, prior to screening.
3.2.3 Screening Clones for Plasmids Containing Relevant PCR 
Products 
To determine whether or not a transformant’s plasmid contains a PCR product of 
interest a ‘screening method’ was devised, this method is validated in Chapter 4. The 
method applied is presented, in full, below.
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3.2.3.1 Direct Colony PCR
Direct Colony PCR is a quick and efficient screening method used to determine 
whether a colony contains a plasmid and an inserted PCR product, in this case clones 
were screened for PCR product inserts amplified by the primer combination: 
109F/927R. The unpublished method required a colony to be placed into 200µL of 
DNA-free water, vortexed, spun down at 13K for 2mins. 1µl of the supernatant was 
added to a 25µL PCR reaction mix, containing the 109F/927R primers. The PCR was 
carried out using the protocol: DM55LONG. Products were then gel electrophoresed, 
illuminated by UV light and photographed; colonies that displayed a product ~900bp 
in size were streaked out for single colonies on LB/Kan plates.
3.2.4 Preparation of Plasmid DNA for Sequencing
Preceding sequencing, plasmids had to be isolated from cultures of each transformant
and diluted to the correct concentration.
3.2.4.1 Plasmid DNA Preparation
The pCR® 2.1-TOPO plasmid (Invitrogen, 2004) was isolated from the selected 
transformants that were streaked out for single colonies. Universals containing 5mL
of Terrific Broth containing Kanamycin at a final concentration of 50ug/mL and 
Glucose at a final concentration of 0.1%, were inoculated with cells from a single 
colony and incubated overnight at 37°C with vigorous aeration. The following day 
they were placed on ice for 10mins, 1.5mL quantities of culture were spun down 
sequentially two times into 1.5mL tubes and the cells finally resuspended in 200µL of 
cold GTE (50mM glucose, 25mM Tris HCl pH8.0, 10mM EDTA pH8.0). 0.2M 
Sodium Hydroxide/1% Sodium Dodecyl Sulfate was then added and mixed by 
inversion. 300µL 3M Potassium Acetate pH 5.2 was mixed in and a white clot 
formed. The tubes were placed on ice for 10mins before being spun down at 13K for 
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10mins. The supernatant was treated with 1µL of 20mg/ml RNAse (DNAse free) for 
20mins in a 37°C water bath. 600µL Chloroform was mixed in by inversion to 
solubilize unwanted proteins, the tubes contents were then spun at 13K for 1min, this 
Chloroform step was repeated on the top aqueous phase. 600µL Isopropanol was then 
added to the top aqueous phase to precipitate DNA. Spun at 13K for 10mins, the 
Isopropanol was then removed by pipette and the DNA pellet washed with 500µL of 
ice cold Ethanol, this was spun at 13K for 2mins and the Ethanol removed by pipette. 
The pellet was air dried, re-suspended in 96µL of water. The DNA was once again 
precipitated by the addition and mixing of 24µL Sodium Chloride and 120 µL 13% 
PEG 8000, the tube was put on ice for 20mins then spun at 13K for 25mins at 4°C. 
The supernatant was removed and the DNA pellet washed with 400µL  ice cold 
Ethanol. Once the Ethanol was removed by pipette and air drying, the pellet was 
resuspended in 20µL of TE10/0.1, and the tube stored at -20°C. 
3.2.4.1.A Gel Electrophoresis Check
To evaluate the quality and establish an idea of the quantity of re-suspended 
plasmid DNA, solutions were run on large TAE, 0.9% agarose gels for 1hr, at 
110V. These were illuminated by UV light and photographed using Scion 
imager.
3.2.4.1.B Determination of DNA concentration using a Nanodrop 
Spectrophotometer
To verify this information and give a numerical value to the concentration of 
plasmid DNA preparations, 2µL of re-suspended plasmid solutions were 
measured on a Nanodrop® ND-1000 Spectrophotometer, adhering to the 
protocol outlined in the Nanodrop V3.1.0 User’s Manual (Nanodrop-
Technologies, 2004).
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3.2.4.1.C Dilution of Plasmid DNA
The Waikato DNA Sequencing Facility requires 12µL of plasmid DNA at a 
concentration of ~100ng/µL  prior to sequencing. Dilution was achieved using 




3.3.1 PCR Product Isolation
PCR products of interest were isolated prior to cloning by PCR amplification of the 
human mucosal surface sample DM20 using various primer sets. Bands of interest 
were excised from gels, by ‘bandstab’. Excised bands were re-suspended before 
undergoing a further round of PCR, in order to check whether the correct band was 
removed and amplified, the remaining PCR mix was purified and precipitated using a
PEG/MgCl2 method with a small amount checked on a gel. The remaining 
concentrated precipitate was subsequently used in cloning, transformation and 
screened prior to sequencing.
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3.3.1.1 5’ End Extension
3.3.1.1.A 1AF/927R and 1AF/927R NEW Bandstabs
The figures shown below (Figures: 3.3-A and B) depict the results of the 
initial PCR carried out using the human mucosal surface sample DM20 
template and the primer sets 1AF/927R and 1AF/927R NEW, and the 
succeeding ‘bandstab’ excisions of the relevant PCR products.
 A     1      2      3              4      5      6            7   A     1      2      3              4      5     6             7
Figure 3.3-A: Small TBE gel displaying PCR 
products obtained using human mucosal surface 
sample DM20 and 1AF/927R or 927R NEW
primer sets. A, 100bp ladder; 1-3, 1AF/927R; 4-6, 
1AF/927R NEW; 7, Positive control.
Figure 3.3-B: The gel from Figure 3.3-A
after the excision of the PCR product of 
interest at ~900bp.
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3.3.1.1.B Verification of 1AF/927R and 1AF/927R NEW Bandstabs and their 
PEG/MgCl2 Precipitation
To verify whether the excision of the PCR products and their purity were 
successful a further round of PCR with the same primer sets from Figure 3.3-
A was carried out using the supernatant of the re-suspended gel excision as a 
template. The results for each of the primer sets can be seen below in Figure
3.3-C.
   A           1          2       3          4         5          6          7          8           9       10     11     12
Figure 3.3-C: Large TAE gel depicting: 1-6, PCR amplicons produced for the six ‘bandstabs’ carried 
out in Figure 3.3-B; 7-12 PEG/MgCl2 PCR product precipitations of 1-6 respectively.
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3.3.1.1.C 1AF/927R and 927R NEW Direct Colony PCR Screening
The ‘screening method’ outline in Chapter 4 was used here, an example is 
seen below in Figure 3.3-D. 1AF/927R transformants underwent PCR with 
the 109F/927R primer set (1AF/927R NEW transformants were amplified 
with the 109F/927R NEW primer set), to amplify sequences that contained
either the known sequence or those of a similar nature. These methods were 
repeated for all applicable primer sets (1AF/927R or 927R NEW; 
109F/1391R), building a small library of sequences to analyse.
A      1   2     3     4     5     6      7      8     9    10
Figure 3.3-D: Small TAE gel depicting a 
direct colony PCR result of 1AF/927R 
transformants with the primer set 109F/927R. 
A, 100kb ladder; 1-10, 1AF/927R 
transformants amplified with the 109F/927R 
primer set.
   A              1       2       3       4       5       8     10
Figure 3.3-E: TAE gel displaying the plasmid 
isolation of the selected transformants from Figure 
3.3-D. NB: The selected transformant 6 was lost 
during the precipitation procedure and is absent.
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3.3.1.2 3’ End Extension
3.3.1.2.A 109F and 109F NEW /1391R Bandstabs and Verification
Figure 3.3-F depicts the results of the initial PCR carried out using the human 
mucosal surface sample DM20 and the primer sets 109F/1391R and 109F 
NEW/1391R NEW. The labelled bands (A-F) in Figure 3.3-E were 
subsequently excised by ‘bandstab’. The amplification of these ‘bandstabs’ 
were inconclusive for both of the aforementioned primer sets (Figure 3.3-G).
It was this result that led to the precipitation of the entire original PCR result 
from Figure 3.3-F, with the objective being to clone a number of amplicons,
ideally containing the ‘known sequence’.
A          1        2                   3           4           B    A            2A  2B    2C          4D   4E   4F
Figure 3.3-F: Small TBE gel displaying PCR 
amplicons obtained using the human mucosal 
surface sample DM20 and the 109F or 109F 
NEW/1391R primer sets. A, 100bp ladder; 1-
2, 109F/1391R; 3-4, 109F/1391R NEW; B, 
100kb ladder; A-F, bands excised by 
‘bandstab’ for PCR.
Figure 3.3-G Small TBE gel displaying PCR      
results of ‘bandstabs’ from Figure 3.3-E.  A, 
100bp ladder; 2A-2C, PCR results of excisions
A-C; 4D-4F, PCR results of excisions D-F.
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3.3.1.2.B 109F/1391R PCR Product Precipitation
Amplification of the excised bands (A-F) in Figure 3.3-F, proved to be 
unreliable (Figure 3.3-G, the entire raw PCR result from the 109F/1391R 
primer set was PEG/MgCl2 precipitated for cloning. The results of the 
PEG/MgCl2 precipitation is below in Figure 3.3-H.
    A               1      2       3       4       5       6                7      8
Figure 3.3-H: Small TAE gel depicting PCR and PEG/MgCl2 PCR product 
precipitations : A, 100kb ladder; 1,3,5, 109F/1391R; 2,4,6 PEG/MgCl2 PCR 
product precipitations of 1,3,5 respectively; 7, Positive control: DM20(1:10 
dilution) with the primer set 109F/927R; 8, PEG/MgCl2 PCR product 
precipitations of 7. All PCR products were obtained using human mucosal 
surface sample DM20. 
-64-
3.3.1.2.C 109F/1391R Direct Colony PCR
109F/1391R transformants were subjected to the same ‘screening’ process as 
the 1AF/927R or 927R NEW transformants in 3.3.1.1. Direct colony PCR was 
carried out with the primers 109F/927R so that those that contained 
potentially relevant sequences (brighter bands) could be selected for plasmid 
precipitation and sequencing. The selected colonies were: 1, 4, 5, 6, 13 and 
20.
  A       1      2    3    4     5    6      7      8    9   10   11  12    13   14    15  16    17   18    19  20   B
Figure 3.3-I: Large TAE gel displaying the direct colony PCR of 109F/1391R transformants with the 
109F/927R primer set: A, 100kb ladder; 1-20, 109F/1391R transformants amplified with109F/927R; 
B, Positive control: DM20(1:10 dilution) with the primer set 109F/927R.
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3.3.1.2.D 109F/1391R Plasmid Isolation Verification
To verify the quality and give an insight into the quantity of the plasmid 
present following precipitation of the chosen transformant colonies in 
duplicate (A and B) from Figure 3.3-J small amounts of each plasmid was gel 
electrophoresed.
   A                    1         1A        4        4A         5       5A          6       6A      13       13A    20    20A
Figure 3.3-J: Large TAE gel depicting the plasmid DNA precipitated from the 109F/1391R 
transformants selected from the 'screening method' in Figure 3.3-I.  Each selected (1-20A) 
transformant was isolated and precipitated in duplicate. 
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3.4 Discussion
3.4.1 5’ End Extension of ‘Known’ Sequence
To extend the 5’ end of the ~830bp ‘known’ sequence from the aforementioned 
preliminary studies, PCR was carried out using the primer sets: 1AF/927R or 927R 
NEW, with the human mucosal surface sample DM20 as a template. The theoretical 
size of the manufactured amplicon was ~927bp, therefore it was our aim to isolate 
this PCR product, or any within this range, for cloning and transformation, and from 
there preparation for sequencing and analysis could begin.
3.4.1.1 1AF/927 R or 927R NEW PCR Product Isolation for Cloning and 
Transformation
PCR was carried out in triplicate using both primer sets: 1AF/927R or 927R NEW, 
with the human mucosal surface sample DM20 as a template. Results are shown in 
Figure 3.3-A, both primer sets amplified similarly, with a bright band in all 
amplifications just above the 900bp mark illustrated by the 100kb ladder in track A. 
These PCR products were believed to be candidates for the 5’ extended version of the 
‘known’ sequence, and were therefore flagged for isolation, cloning and 
transformation.
Isolated PCR products were attained using the ‘bandstab’ method described in 
3.2.1.3. The outcome of the excision performed on the applicable bands is presented 
in Figure 3.3-B. These excised products were then checked for purity by repeating the 
PCR with the respective primer sets, the PCR products were also PEG/MgCl2
precipitated, in order to enhance purification and increase concentration prior to 
cloning; the results are exhibited in Figure 3.3-C. In Figure 3.3-C (1-6), the excised 
band from Figure 3.3-B ‘re-amplified’ brighter and with a marked decrease in non-
specific ‘noise’. The precipitation of the ‘re-amplified’ excised bands (7-12) showed 
little if any decrease in intensity, indicating a successful precipitation. The purity of 
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the isolated PCR products were also slightly increased as the precipitations displayed 
some decrease in non-specific ‘noise’.
These purified and concentrated PCR products were inserted into a pCR® 2.1-TOPO 
plasmid vector (Figure 3.2-A) following the TOPO® Cloning Reaction  outlined in the 
TOPO TA Cloning® Instruction Manual (Version R), Invitrogen ™ (see 3.2.2). The 
vector was then transformed into One Shot® TOP10 Competent Cells adhering to the 
method described in TOPO TA Cloning® Instruction Manual (Version R), Invitrogen 
™ (see 3.2.2.2). Transformants were then spread out on LB/Kan plates containing X-
gal (see 3.2.2.3) with white cell colonies being selected to undergo the subsequent 
‘screening’ process, in an effort to find transformants that harbored relevant PCR 
product sequences.
3.4.1.2 Screening Transformant Plasmids for Sequencing
The ‘screening method’ outlined in 3.2.3 and validated in Chapter 4, was employed to 
filter out transformant colonies that contained PCR products that were not of interest. 
This was accomplished using the 109F/927R or 109F/927R NEW primer sets in 
direct colony PCR, in the expectation that, only colonies containing relevant 
sequences would be targeted and produce a PCR product ~830bp. This would narrow 
down the sum of transformant colonies that would ultimately have their plasmids 
precipitated and their PCR product insert sequenced.
An example of the ‘screening method’ for the 5’ end extension sequence is shown in 
Figure 3.3-D and 3.3-E. Figure 3.3-D displays the outcome of a direct colony PCR 
(see 3.2.3.1), with 1AF/927R transformant colonies and the primer set: 109F/927R. 
All bright bands located ~830bp (1, 2, 3, 4, 5, 6, 8 and 10) were of interest and their 
corresponding transformant colonies went on to have their plasmids precipitated for 
sequencing.  Bands (7 and 9) from Figure 3.3-D that displayed non-specific binding 
or no amplification whatsoever were excluded.
Selected transformant colonies had their plasmids precipitated, checked and measured
following the protocols detailed in 3.2.4. Figure 3.3-E is an example of the plasmid 
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DNA check (3.2.4.1.A) carried out on plasmids precipitated from transformants. In 
this case Figure 3.3-E displays the plasmid precipitations of the selected 
transformants from Figure 3.3-D. Due to the sensitive nature of the plasmid 
preparation procedure it was not uncommon to lose the precipitated plasmid DNA 
pellet during its final ethanol wash (see 3.2.4.1), in this example 6 was lost and is 
absent from Figure 3.3-E.
After the plasmids were precipitated they were checked and measured by both gel and 
Nanodrop® ND-1000 Spectrophotometer following the methods in 3.2.4.1.A and 
3.2.4.1.B. Using this information plasmid DNA was diluted to a concentration of 
(~100ng/µL) (see 3.2.4.1.C) and sent to the Waikato DNA Sequencing Facility for 
sequencing (Refer to Chapter 5 for sequencing results and analysis).
3.4.2 3’ End Extension of ‘Known’ Sequence
To extend the 3’ end of the ‘known’ sequence from aforementioned preliminary 
studies, PCR was carried out using the primer sets: 109F or 109F NEW/1391R, with 
the human mucosal surface sample DM20 as a template. The theoretical size of the 
manufactured amplicon was ~1282bp, therefore it was our aim to isolate this PCR 
product, or any within this range, for cloning and transformation, and from there,
preparation for sequencing and analysis could begin.
3.4.2.1 109F/1391R PCR Product Isolation for Cloning and 
Transformation
PCR was carried out in duplicate using both primer sets: 109F/1391R and 109F 
NEW/1391R, with the human mucosal surface sample DM20 as a template. Results 
are shown in Figure 3.3-F, both primer sets amplified similarly, with bright  bands at 
~1000, 1200 and 1400bp as illustrated by the 100kb ladder in track A. These 6 PCR 
products (labeled A-F respectively) were believed to be potential candidates for the 5’ 
extended version of the ‘known’ sequence, and were therefore flagged for isolation, 
cloning and transformation.
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The same method of ‘bandstabbing’ candidate bands as in 3.3.1.1.A proved to be 
unsuccessful. The outcome of the excision and subsequent ‘re-amplification’ with the 
primer sets 109F/1391R or 109F NEW/1391R performed on the applicable bands (A-
F) is presented in Figure 3.3-G. It can be seen that there is some amplification for 
bands A-C from Figure 3.3-F (2A-2C in Figure 3.3-G), with a major product at 
~400bp and some accompanying non-specific products. Reamplified bands D-F in 
Figure 3.3-F displayed little or no amplification, as seen in Figure 3.3-F (4D-4F), 
with either a small product under 100bp or a primer dimer having been produced. In 
light of this failure it was decided that the entire raw PCR product for only 
109F/1391R would be PEG/MgCl2 precipitated, and not 109F NEW/1391R as it was 
considered superfluous.
Figure 3.3-H portrays the entire raw PCR product for the 109F/1391R primer set with
the human mucosal surface sample DM20 as a template (1, 3 and 5) and the 
PEG/MgCl2 precipitation of each (2, 4, and 6), this was prepared in triplicate. The 
precipitations were successful and allowed for cloning, it was thought that all of the 
non-specific products would by cloned into the vector, including some of the relevant 
sequences that may have belonged to the potential candidate bands circled in Figure 
3.3-F.  
The precipitated and concentrated raw PCR product from Figure 3.3-H (2) was 
inserted into a pCR® 2.1-TOPO plasmid vector (Figure 3.2-A) following the TOPO®
Cloning Reaction  outlined in the TOPO TA Cloning® Instruction Manual (Version 
R), Invitrogen ™ (see 3.2.2). The vector was then transformed into One Shot® TOP10 
Competent Cells adhering to the method described in TOPO TA Cloning® Instruction 
Manual (Version R), Invitrogen ™ (see 3.2.2.2). Transformants were then spread out 
on LB/Kan plates containing X-gal (see 3.2.2.3) with white cell colonies being 
selected to undergo the subsequent ‘screening’ process, in an effort to find 
transformants that harbored relevant PCR product sequences.
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3.4.2.2 Screening Transformant Plasmids for Sequencing
The ‘screening method’ outlined in 3.2.3 and validated in Chapter 4, was applied to 
filter out transformant colonies that contained PCR products that were not of interest. 
This was accomplished using the 109F/927R primer set in direct colony PCR, in the 
expectation that, only colonies containing relevant sequences would be targeted and 
produce a PCR product ~830bp. This would narrow down the sum of colonies that 
would have their plasmids precipitated and their PCR product insert sequenced.
Unfortunately, the ‘screening method’ used in the 5’ extension (3.3.1.1) did not 
function in the same manner as when applied to the 3’ extension (3.3.1.2). The 
application of the ‘screening method’ to the 3’ extension was tested in Chapter 4 and 
illustrated the method, in respect to the 3’ extension, to be flawed. To maintain 
consistency and avoid constant sequencing or totally irrelevant and unwanted 
sequences the ‘screening method’ was used throughout the project.
Use of the ‘screening method’ for the 3’ end extension sequence is shown in Figure 
3.3-I and 3.3-J. Figure 3.3-I displays the outcome of a direct colony PCR (see 
3.2.3.1), with 109F/1391R transformant colonies and the primer set: 109F/927R. All 
bright bands located ~830bp (1, 4, 5, 6, 13 and 20) were of interest and these 
transformant colonies went on to have their plasmids precipitated for sequencing.  
Bands (2, 3, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 18 and 19) showed weaker or no 
amplification whatsoever and were consequently excluded.
Selected transformant colonies had their plasmids precipitated, checked and measured 
following the protocols detailed in 3.2.4. Figure 3.3-J is an example of the plasmid 
DNA check (3.2.4.1.A) carried out on plasmids precipitated from transformants. In 
this case Figure 3.3-J displays the plasmid precipitations of the selected transformants 
from Figure 3.3-I. 
After the plasmids were precipitated they were checked and measured by both gel and 
Nanodrop® ND-1000 Spectrophotometer following the methods in 3.2.4.1.A and 
3.2.4.1.B. Using this information plasmid DNA was diluted to a concentration of 
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(~100ng/µL) (see 3.2.4.1.C) and sent to the Waikato DNA Sequencing Facility for 
sequencing (refer to Chapter 5 for sequencing results and analysis). 
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3.5 Conclusion
Isolation of the amplicons produced by the 1AF/927R or 927R NEW primers sets 
with the DM20 human gastrointestinal mucosal DNA template was relatively 
successful. The isolation of the 109F/1391R amplicons was not successful; therefore 
the use of precipitated, raw PCR products in cloning was to be carried out in this 
case. The hope was that at least some of the relevant amplicons would be inserted 
into plasmids and eventually be sequenced. 
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Chapter 4: Validation of Screening Methodology
4.1 Introduction
The ‘screening method’ was devised to filter out colonies that contained PCR 
products that were not of interest. This was accomplished using the 109F/927R or 
109F/927R NEW primer sets in the expectation that, only colonies containing 
relevant sequences would be targeted. This would narrow down the sum of colonies 
that would have their plasmids precipitated and their PCR product insert sequenced.
4.2 Materials and Methods
4.2.1 Direct Colony PCR 
Direct colony PCRs were carried out following the procedure outlined in (2.6.3.1), 
with the 109F/927R or 109F/927R NEW primer sets.
4.2.2 Gel electrophoresis
Gel electrophoresis of PCR products was carried out following the procedure outlined 
in
4.2.3 Preparation of Plasmid DNA for Sequencing
4.2.3.1 Gel Electrophoresis Check
A qualitative and quantitative check of the re-suspended plasmid DNA were carried 
out using gel electrophoresis as explained in 3.2.4.1.A. 
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4.2.3.2 Determination of DNA concentration using a Nanodrop        
spectrophotometer
The quantity of re-suspended plasmid DNA was determined using a Nanodrop® ND-
1000 Spectrophotometer following the method detailed in 3.2.4.1.B.
4.2.3.3 Dilution of Plasmid DNA
The plasmid DNA concentration requirements for sequencing were reached adhering 
to the procedure in 3.2.4.1.B. 
4.2.4 Sequencing
Plasmid DNA was sequenced by the Waikato DNA Sequencing Facility, Hamilton, 
New Zealand. Adhering to the requirements stipulated on their website 
(http://bio.waikato.ac.nz/sequence/), sequences were determined using the M13 
Forward Primer provided with the TOPO® Cloning Reaction Kit (binding site shown 
in Fig.1 above) and Applied Biosystems Big Dye v3.1 chemistry.
4.2.5 Analysis of Sequencing Results
4.2.5.1 Chromas
Electropherogram sequence results were edited in Chromas 2.33, Technelysium Pty 
Ltd. Flanking vector and primer sequences were manually removed from the 
sequence of interest and the integrity of the sequence was also monitored and 
sequence of low integrity was also removed prior to further analysis being carried 
out. 
4.2.5.2 ClustalW2
Edited sequences were submitted for analysis, along with the DM1 consensus 
sequence obtained from preliminary work, to the DNA/Protein multiple sequence 
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alignment program ClustalW2, located on the European Bioinformatics Institute 
(EBI) website (http://www.ebi.ac.uk/Tools/clustalw2/index.html). 
4.2.5.3 BLAST
Edited sequences were submitted to BLAST located on the National Biocenter for 
Biotechnology Information (NCBI) website (http://blast.ncbi.nlm.nih.gov/Blast.cgi) 
for analysis. The parameters for BLAST were: Nucleotide BLAST; Non-redundant 
Database (Nucleotide Collection (nr/nt); Megablast (optimised for highly similar 
sequences).
4.2.5.4 Classifier
Edited sequences were submitted for analysis to the Classifier program located on the 
Ribosomal Database Project (RDP) website 
(http://rdp.cme.msu.edu/classifier/classifier.jsp). The classification algorithm that 
aligned 16S rRNA sequences was designed by (Q. Wang et al., 2007)
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4.3 Results
4.3.1 Direct Colony PCR of 1AF/927R Transformants with 
109F/927R Primers and Analysis of Sequences
Transformant colonies presumably containing 1AF/927R PCR product inserts 
underwent direct colony PCR (Figure 4.3-A), the plasmids were then precipitated and 
the inserts sequenced and analyzed (Table 4.3-A).
.    A             1       2          3         4         5         6          7          8        9         10       B
Figure 4.3-A: A, 100kb ladder; 1-10, 1AF/927R transformant colonies from reference plate amplified 
with the primer set: 109F/927R; 11, Positive control: DM20(1:10 dilution) with the primer set 
109F/927R.  1-9 were selected for sequencing.
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Table 4.3-A: Sequence results and analysis for 1-9 from figure 4.3-B above, the highlighted rows are ‘hits’ found in BLASTand Classifier that come from Firmicutes  
and sequences obtained from the human gastrointestinal tract.
Primers 109F/927R BLAST No. Best Blast Hit Reference Classifier Result Division
(Date_Primer Set_No.)
Product: 1AF/927R
300908_1AF_927R_ 1 DQ807184.1 Uncultured bacterium clone RL244_aaj47c08 Gordon et al. 2006 Lachnospiraceae Incertae Sedis Firmicute
300908_1AF_927R _ 2 AC010093.8 Homo sapiens BAC clone RP11-323O5 Levy et al. 2001 Unclassified Root N/A
300908_1AF_927R _ 3 DQ807184.1 Uncultured bacterium clone RL244_aaj47c08 Gordon et al. 2006 Unclassified Lachnospiraceae Firmicute
300908_1AF_927R _ 4A AC106827.2 Homo sapiens chromosome 3, RP11-320P11 Haugen et al. 2002 Unclassified Root N/A
300908_1AF_927R _ 5 AY977855.1 Uncultured bacterium clone LF53 Relman et al. 2005 Roseburia Firmicute
300908_1AF_927R _ 6 AC011597.27 Homo sapiens 3 BAC RP11-85F14 Worley et al. 1999 Unclassified Root N/A
300908_1AF_927R _ 7 AC011597.27 Homo sapiens 3 BAC RP11-85F14 Worley et al. 1999 Unclassified Root N/A
300908_1AF_927R _ 8 AC093014.11 Homo sapiens 12 BAC RP11-734E19 Worley et al. 2001 Unclassified Bacteria N/A
300908_1AF_927R _ 9 DQ807184.1 Uncultured bacterium clone RL244_aaj47c08 Gordon et al. 2006 Lachnospiraceae Incertae Sedis Firmicute
4.3.2 Direct Colony PCR of 109F/1391R Transformants with 109F/927R Primers and Analysis of 
Sequences
After completing the validation above in 4.3.1, it was thought that the same ‘screening method’ would be applied to transformant colonies 
presumably containing 109F/1391R PCR product inserts. In this case only the ‘brighter’ bands in a direct colony PCR (Figure 4.3-B), had 
their corresponding transformant colony’s plasmids precipitated and the inserted PCR products sequenced and analyzed (Table 4.3-B).
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                                   A            1      2    3    4     5    6      7      8    9   10   11  12    13   14    15  16    17   18    19  20     B
Figure 4.3-B: Large TAE gel displaying the direct colony PCR of 109F/1391R transformants with the 109F/927R primer set: A, 100kb ladder; 1-20, 109F/1391R 
transformants amplified with109F/927R; B, Positive control: DM20(1:10 dilution) with the primer set 109F/927R. 4, 5, 6, 13 and 20 were selected for sequencing and 
analysis.
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Table 4.3-A: Sequence results and analysis for 1-9 from figure 4.3-B above, the highlighted rows are ‘hits’ found in BLASTand Classifier that come from Firmicutes  
and sequences obtained from the human gastrointestinal tract.
Sequence
BLAST 
No. Best Blast Hit Reference Classifier Result Division
109F/1391R:
270108_109F_1391R _4 AC209419.4
Homo sapiens FOSMID clone 
ABC9-43925600O21
Wilson,R.K. 2007 Unclassified Root N/A
270108_109F_1391R _5 AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 Unclassified Root N/A
270108_109F_1391R _6 AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 Unclassified Root N/A
270108_109F_1391R _20 AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 Unclassified Root N/A
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4.4 Discussion
4.4.1 1AF/927R and 1AF/927R NEW Screening Method
1AF/927R transformant colonies were selected for direct colony PCR (Figure 4.3-A), 
plasmids were then precipitated from the selected transformants and sequenced. 
Sequences were edited in Chromas and submitted to BLAST and Classifier to better 
identify them. These results can be viewed in Table 4.3-A.
BLAST and Classifier results designated ‘brighter’ bands from tracks: 1, 3, 5, and 9
as relevant Firmicute sequences that were similar to those described in the literature
that were also sourced from the human gastrointestinal tract. The ‘less bright’ bands 
from tracks: 2, 4, 6, 7, and 8 gave unclassified roots and divisions in Classifier and 
BLAST ‘hits’ with Homo sapiens DNA and are thus expected to be the result of non-
specific amplification.
As our known sequence belonged to the Mollicute Class and in turn the bacterial 
Division of the Firmicutes, it was reasoned that all the ‘brighter’ bands that gave 
Firmicute sequences, would be selected and sequenced; ‘less bright’ bands would be 
excluded.
4.4.2 109F/1391R Screening Method
109F/1391R transformant colonies were selected for direct colony PCR (Figure 4.3-
B), selected transformant colonies then had their plasmids precipitated and 
sequenced. These sequences were edited in Chromas and submitted to BLAST and 
Classifier to better identify them. These results can be viewed in Table 4.3-B.
BLAST and Classifier results designated the selected ‘brighter’ bands from tracks: 4, 
5, 6, 13 and 20 (13 was lost in the precipitation process and is absent from Table 4.3-
B). None of the analysed sequences were Classified as Firmicutes, in fact all the 
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sequences were Classified as having ‘Unclassified Roots’ and having BLAST ‘hits’ 
with  Homo sapiens DNA; these results are expected to be the result of non-specific 
amplification by the 109F/1391R primer set.
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4.5 Conclusion
The ‘screening method’ outlined in this chapter displayed itself as a viable selection 
method for 1AF/927R transformant plasmids that contained PCR product inserts that 
belonged to potential Firmicutes inhabiting the human gastrointestinal tract. 
Due to similarity between the reverse primers 927R and 927R NEW, the ‘screening 
method’ was employed throughout the project, against the PCR product inserts 
attained from the template DM20 (sample isolated from the human gastrointestinal 
tract) and the primer sets: 1AF/927R or 927R NEW. This method was seen as means 
of saving time, labour and laboratory resources.
Although the ‘screening method’ was inefficient when applied to transformants 
containing 109F/1391R amplicons, all transformant colonies underwent the same 
process, to keep consistency throughout the project.
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Chapter 5: Sequence Analysis
5.1 Introduction
The PCR products were isolated, cloned and transformed, these transformants then 
underwent the ‘screening process’ outlined in Chapter 4. ‘Selected’ transformants had 
their plasmids precipitated and prepared for sequencing. Chapter 5 gives the 
sequencing results and analysis of those inserted PCR product.
5.2 Material and Methods
5.2.1 Sequencing
Plasmid DNA was sequenced by the Waikato DNA Sequencing Facility, Hamilton, 
New Zealand. Adhering to the requirements stipulated on their website 
(http://bio.waikato.ac.nz/sequence/), sequences were determined using the M13 
Forward Primer provided with the TOPO® Cloning Reaction Kit (binding site shown 
in Fig.1 above) and Applied Biosystems Big Dye v3.1 chemistry.
5.2.2 Analysis of Sequencing Results
5.2.2.1 Chromas
Electropherogram sequence results were edited in Chromas 2.33, Technelysium Pty 
Ltd. Flanking vector and primer sequences were manually removed from the 
sequence of interest and the integrity of the sequence was also monitored and 




Edited sequences were submitted for analysis, along with the DM1 consensus 
sequence obtained from preliminary work, to the DNA/Protein multiple sequence 
alignment program ClustalW2, located on the European Bioinformatics Institute 
(EBI) website (http://www.ebi.ac.uk/Tools/clustalw2/index.html). 
5.2.2.3 BLAST
Edited sequences were submitted to BLAST located on the National Biocenter for 
Biotechnology Information (NCBI) website (http://blast.ncbi.nlm.nih.gov/Blast.cgi) 
for analysis. The parameters for BLAST were: Nucleotide BLAST; Non-redundant 
Database (Nucleotide Collection (nr/nt); Megablast (optimised for highly similar 
sequences).
5.2.2.4 Classifier
Edited sequences were submitted for analysis to the Classifier program located on the 
Ribosomal Database Project (RDP) website 
(http://rdp.cme.msu.edu/classifier/classifier.jsp). The classification algorithm that 
aligned 16S rRNA sequences was designed by (Q. Wang et al., 2007).
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5.3 Results











DM1 Consensus DQ797049.1 Uncultured bacterium clone RL386_aao86c09 Ley et al. 2006 91/99 Anaeroplasma Firmicute
1AF/927R:
(Date_Primer Set_No.)
040608_1AF_927R_3 DQ807184.1 Uncultured bacterium clone RL244_aaj47c08 Ley et al. 2006 99/99 Lachnospiraceae Incertae Sedis Firmicute
210808_1AF_927R_2 DQ807184.1 Uncultured bacterium clone RL244_aaj47c08 Ley et al. 2006 88/98 Unclassified Lachnospiraceae Firmicute
210808_1AF_927R 6A DQ802576.1 Uncultured bacterium clone RL188_aan93f02 Ley et al. 2006 100/98 Faecalibacterium Firmicute
300908_1AF_927R_ 1 DQ807184.1 Uncultured bacterium clone RL244_aaj47c08 Ley et al. 2006 99/98 Lachnospiraceae Incertae Sedis Firmicute
300908_1AF_927R_ 3 DQ807184.1 Uncultured bacterium clone RL244_aaj47c08 Ley et al. 2006 99/97 Unclassified Lachnospiraceae Firmicute
210808_1AF_927R _8A DQ807184.1 Uncultured bacterium clone RL244_aaj47c08 Ley et al. 2006 100/98 Lachnospiraceae Incertae Sedis Firmicute
300908_1AF_927R_ 9 DQ807184.1 Uncultured bacterium clone RL244_aaj47c08 Ley et al. 2006 99/98 Lachnospiraceae Incertae Sedis Firmicute
040608_1AF_927R_5 AY977855.1 Uncultured bacterium clone LF53 Eckburg et al. 2005 99/97 Roseburia Firmicute
210808_1AF_927R _10 EF403800.1 Uncultured bacterium clone SJTU_A2_03_21 Zhao et al. 2007 99/98 Faecalibacterium Firmicute
210808_1AF_927R _5 EF404855.1 Uncultured bacterium clone SJTU_G_09_34 Zhao et al. 2007 99/95 Ruminococcaceae Incertae Sedis Firmicute
210808_1AF_927R _7A EF404855.1 Uncultured bacterium clone SJTU_G_09_34 Zhao et al. 2007 100/95 Ruminococcaceae Firmicute
210808_1AF_927R _3A EU139255.1 Ruminococcus gnavus strain A2 Nicoli et al. 2007 100/97 Unclassified Lachnospiraceae Firmicute
300908_1AF_927R_ 5 AY977855.1 Uncultured bacterium clone LF53 Relman et al. 2005 99/99 Roseburia Firmicute
210808_1AF_927R _9 EU762168.1 Uncultured bacterium clone Ax2_123 Relman et al. 2008 99/99 Faecalibacterium Firmicute
040608_1AF_927R_7 CP000383.1 Cytophaga hutchinsonii ATCC 33406 McBride et al. 2006 99/97 Cytophaga Bacteriodetes
040608_1AF_927R_2 DQ807609.1 Uncultured bacterium clone RL307_aam08h03 Ley et al. 2006 99/97 Bacteriodes Bacteriodetes
040608_1AF_927R_4 DQ447856.1 Uncultured bacterium clone MSFC_4M9I Venkateswaran et al. 2006 99/99 Cloacibacterium Bacteriodetes
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Figure 5.3-A: Phylogram output from ClustalW2 of the highlighted 1AF/927R sequences from Table 5.3-A and the DM1 'known' Consensus Sequence
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DM1 Consensus DQ797049.1 Uncultured bacterium clone RL386_aao86c09 Ley et al. 2006 91/99 Anaeroplasma Firmicute
1AF/927RNEW:
(Date_Primer Set_No.)
040608_1AF_927Rn_19 DQ798083.1 Uncultured bacterium clone RL302_aal95c11 Ley et al. 2006 99/97 Faecalibacterium Firmicute
200808_1AF.927Rn_8 DQ807308.1 Uncultured bacterium clone RL244_aaj48h11 Ley et al. 2006 94/99 Lachnospiraceae Incertae Sedis Firmicute
200808_1AF.927Rn_5 DQ807308.1 Uncultured bacterium clone RL244_aaj48h11 Ley et al. 2006 100/99 Lachnospiraceae Firmicute
200808_1AF.927Rn_6A EU766834.1 Uncultured bacterium clone C1_757 Relman et al.2008 100/99 Faecalibacterium Firmicute
200808_1AF.927Rn_4A EU766834.1 Uncultured bacterium clone C1_757 Relman et al.2008 100/100 Faecalibacterium Firmicute
040608_1AF_927Rn_14 EU765493.1 Uncultured bacterium clone B3_632 Relman et al.2008 100/96 Roseburia Firmicute
200808_1AF.927Rn_2 EU139255.1 Ruminococcus gnavus strain A2 Nicoli et al. 2007 99/99 Unclassified Lachnospiraceae Firmicute
040608_1AF_927Rn_16 EU130959.1 Hydrogenophaga sp. BAC120 Van der Kooij et al. 2007 100/93 Unclassified Root N/A
200808_1AF.927Rn_9A AF035052.1 Beta proteobacterium B6 Szewzyk et al. 99/98 Aquabacterium Proteobacteria
Figure 5.3-B.: Phylogram output from ClustalW2 of the highlighted 1AF/927R NEW sequences from Table 5.3-B and the DM1 'known' Consensus Sequence
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Table 5.3-C: Sequence analysis of the 109F/1391R amplicons. 







131008_109F_1391R_R3A EU881319.1 Uncultured bacterium clone KMS200711-017 Chen,X.B. 2008 99/99 Clostridium Firmicute
270109_109F_1391R _48 EU778429.1 Uncultured bacterium clone RP_2aaa01f05 Gordon,J.I. 2008 100/98 Clostridium Firmicute
131008_109F_1391R_R2A AC091022.4 Homo sapiens chromo 8, RP11-65A5 Birren,B. 2001 100/98 Unclassified Root N/A
131008_109F_1391R_R4 AC087521.10 Homo sapiens chromo 11, RP11-613D13 Birren,B. 2001 100/99 Unclassified Bacteria N/A
131008_109F_1391R_R7 AC087521.10 Homo sapiens chromo 11, RP11-613D13 Birren,B. 2001 100/98 Unclassified Root N/A
270109_109F_1391R _62 CU634019.4 Human DNA CH507-236L23 on chromo 21 Collins,J. 2009 99/99 Unclassified Root N/A
270109_109F_1391R _62A CU634019.4 Human DNA CH507-236L23 on chromo 21 Collins,J. 2009 98/99 Unclassified Root N/A
270109_109F_1391R _65 AC112205.2 Homo sapiens chromo 5 RP11-80G7 DOE Inst.. 2002 98/98 Unclassified Root N/A
131008_109F_1391R_R8A AC009119.10 Homo sapiens chromoe 16 RP11-483P21 DOE Inst. 2002 100/86 Unclassified Root N/A
131008_109F_1391R_R5 AC114485.2 Homo sapiens chromosome 1 RP11-202K23 Kaul,R.K. 2002 98/98 Unclassified Bacteria N/A
270109_109F_1391R _45A NM_000599.3 Homo sapiens insulin-like grwth fac protein5 Park,S.Y. 2008 100/99 Unclassified Root N/A
131008_109F_1391R_B5A AL359457.12 Human DNA sequence from RP11-76K19 Pelan,S. 2009 89/99 Unclassified Root N/A
270109_109F_1391R _59 AC079882.6 Homo sapiens BAC clone RP11-577O18 Wilson,R. 1998 100/99 Unclassified Bacteria N/A
270109_109F_1391R _59A AC079882.6 Homo sapiens BAC clone RP11-577O18 Wilson,R. 1998 100/99 Unclassified Bacteria N/A
270109_109F_1391R _61A AC079882.6 Homo sapiens BAC clone RP11-577O18 Wilson,R. 1998 84/97 Unclassified Bacteria N/A
270109_109F_1391R _66 AC079882.6 Homo sapiens BAC clone RP11-577O18 Wilson,R. 1998 100/98 Unclassified Bacteria N/A
270109_109F_1391R _4 AC209419.4 Homo sapiens FOSMID ABC9-43925600O21 Wilson,R.K. 2007 100/98 Unclassified Root N/A
270109_109F_1391R _30A AC209419.4 Homo sapiens FOSMID ABC9-43925600O21 Wilson,R.K. 2007 99/84 Unclassified Bacteria N/A
270109_109F_1391R _64 AC024887.22 Homo sapiens 3 BAC RP11-307B9 Worley,K.C. 2000 100/98 Unclassified Bacteria N/A
131008_109F_1391R_B4A AC024887.22 Homo sapiens 3 BAC RP11-307B9 Worley,K.C. 2000 91/98 Unclassified Bacteria N/A
131008_109F_1391R_B7 AC024887.22 Homo sapiens 3 BAC RP11-307B9 Worley,K.C. 2000 99/97 Unclassified Bacteria N/A
131008_109F_1391R_B9 AC024887.22 Homo sapiens 3 BAC RP11-307B9 Worley,K.C. 2000 99/98 Unclassified Bacteria N/A
131008_109F_1391R_R9 AC078889.20 Homo sapiens 12 BAC RP11-335I12 Worley,K.C. 2000 100/98 Unclassified Root N/A
131008_109F_1391R_B1A AC092185.3 Homo sapiens 3q BAC RP11-148O7 Worley,K.C. 2001 99/86 Unclassified Bacteria N/A
270109_109F_1391R _5 AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 99/97 Unclassified Root N/A
270109_109F_1391R _5A AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 99/98 Unclassified Root N/A
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270109_109F_1391R _6 AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 91/98 Unclassified Root N/A
270109_109F_1391R _20A AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 99/99 Unclassified Root N/A
270109_109F_1391R _44 AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 97/98 Unclassified Bacteria N/A
270109_109F_1391R _52A AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 99/98 Unclassified Root N/A
270109_109F_1391R _53A AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 99/99 Unclassified Root N/A
270109_109F_1391R _58 AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 100/99 Unclassified Root N/A
270109_109F_1391R _58A AC023593.14 Homo sapiens 3 BAC RP11-427I6 Worley,K.C. 2002 98/99 Unclassified Root N/A
Figure 5.3-C: Phylogram output from ClustalW2 of the highlighted 109F/1391R sequences from Table 5.3-C and the DM1 'known' Consensus Sequence
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5.4 Discussion
The sequences obtained from the WDSF were checked and edited in Chromas, where 
vector, primer and erroneous sequences were removed or if required, excluded. After 
editing the remaining sequences were submitted to both BLAST and Classifier 
(5.2.2). Sequences that showed promise i.e. were sequences that belonged to the 
bacterial division: Firmicutes, were submitted for alignment in the ClustalW2 with 
the ‘known’ sequence representative: DM1 consensus sequence.
5.4.1 5’ End Extension Sequences
The primer sets 1AF/927R and 1AF/927R NEW were designed with the purpose of 
amplifying the 5’ end of the known sequence, extending it from ~830bp to ~930bp. If 
this was achieved the ‘known’ sequence could then become better defined, giving us 
a potential insight into its phylogeny and possibly its functionality and role within the 
human gastrointestinal tract.
5.4.1.1 Sequences from the 1AF/927R Primer Set
Sequences belonging to the inserted PCR products from the ‘selected’ 1AF/927R 
transformants were analysed, with the results placed in Table 5.3-A. Sequences that 
belonged to Firmicutes were highlighted, these sequences were then picked to 
undergo alignment in ClustalW2 with the ‘known’ sequence representative: DM1 
consensus. The result of this alignment is given in the form of a phylogram in Figure 
5.3-A, which depicts the ‘relatedness’ of the sequences.
Of the 17 sequences found in Table 5.3-A, 14 (82%) belonged to the Firmicutes
Division, 11 (65%) of these belonged to the Family Lachnospiraceae and 7 (41%) 
had BLAST ‘hits’ with ‘Uncultured bacterium’ 16S rRNA sequences obtained from 
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the human gastrointestinal tract by (R. E.  Ley et al., 2006), interestingly this was the
same work that the DM1 consensus sequence ‘hit’ when submitted to BLAST (Table 
5.3-A).
Despite ‘hitting’ the same work as the DM1 consensus (R. E.  Ley et al., 2006), none 
of the submitted sequences from Table 5.3-A actually ‘hit’ the same BLAST 
sequence as the DM1 consensus (DQ797049.1). Although the DM1 consensus was 
determined by Classifier to belong to the bacterial Division: Firmicutes like 82% of 
the 1AF/927R amplified sequences, it was placed within the Genus of Anaeroplasma. 
None of the sequences in Table 5.3-A were classified as belonging to Anaeroplasma
Genus, in fact the majority of the Firmicute sequences (79%) belonged to the Family: 
Lachnospiraceae. Lachnospiraceae are part of the Clostridia Class, whereas 
Anaeroplasma is a member of the Mollicutes Class.
The ClustalW2 alignment of all the highlighted Firmicute sequences in Table 5.3-A 
are represented in the phylogram in Figure 5.3-A. The phylogram supports the 
BLAST and Classifier results from Table 5.3-A, the DM1 sequence is similar to the 
others, yet, it is still grouped alone. The other sequences that show similar results in 
Table 5.3-A group together, the DM1 consensus shows some ‘relatedness’ to the 
other sequences but is grouped alone, this is also concordant with the information in 
Table 5.3-A.
Designed to target and 5’ extended version of the ‘known’ sequence it would appear 
that the 1AF/927R primer set did not attain its overall objective. But in sight of this it 
managed to amplify 16S rRNA sequences that belonged to Firmicutes and primarily 
‘hit’ sequences that had been acquired from the human gastrointestinal tract, where of 
course all of the samples from this project were obtained.
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5.4.1.2 Sequences from the 1AF/927R NEW Primer Set
Sequences belonging to the inserted PCR products from the ‘selected’ 1AF/927R 
NEW transformants were analysed, with the results placed in Table 5.3-B. Sequences 
that belonged to Firmicutes were highlighted, these sequences were then picked to 
undergo alignment in ClustalW2 with the ‘known’ sequence representative: DM1 
consensus. The result of this alignment is given in the form of a phylogram in Figure 
5.3-B, which depicts the ‘relatedness’ of the sequences.
Of the 9 sequences found in Table 5.3-B, 7 (78%) belonged to the Firmicutes
Division, of which 4 (44%) belonged to the Family Lachnospiraceae and 3 (33%) 
had BLAST ‘hits’ with ‘Uncultured bacterium’ 16S rRNA sequences obtained from 
the human gastrointestinal tract by (R. E.  Ley et al., 2006), the same work that the 
DM1 consensus sequence ‘hit’ when submitted to BLAST (Table 5.3-B).
Despite ‘hitting’ the same work as the DM1 consensus (R. E.  Ley et al., 2006), none 
of the submitted sequences from Table 5.3-B actually ‘hit’ the same BLAST 
sequence as the DM1 consensus (DQ797049.1). Although the DM1 consensus was 
determined by Classifier to belong to the bacterial Division: Firmicutes like 78% of 
the 1AF/927R amplified sequences, it was placed within the Genus of Anaeroplasma. 
None of the sequences in Table 5.3-B were classified as belonging to Anaeroplasma
Genus, in fact the majority of the Firmicute sequences (57%) belonged to the Family: 
Lachnospiraceae. Lachnospiraceae are part of the Clostridia Class, whereas 
Anaeroplasma is a member of the Mollicutes Class.
The ClustalW2 alignment of all the highlighted Firmicute sequences in Table 5.3-B
are represented in the phylogram in Figure 5.3-B. The phylogram supports the 
BLAST and Classifier results from Table 5.3-B, the DM1 sequence is similar to the 
others, yet, it is still grouped alone. The other sequences that show similar results in 
Table 5.3-A are grouped together; DM1 consensus shows some ‘relatedness’ to the 
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other sequences but is grouped alone, this is also concordant with the information in 
Table 5.3-B.
Equivalent to the 1AF/927R primer set, the 1AF/927R NEW primer set was designed 
to target and 5’ extended version of the ‘known’ sequence, and as with the 1AF/927R 
primer set it would appear that it did not attain its overall objective. Despite this, it 
managed to amplify 16S rRNA sequences that belonged to Firmicutes and primarily 
‘hit’ sequences that had been acquired from the human gastrointestinal tract, where of 
course all of the samples from this project were obtained.
5.4.2 3’ Extension Sequences
The primer sets 109F/1391R and 109F NEW/1391R primer sets were designed with 
the purpose of amplifying the 3’ end of the known sequence, extending it from 
~830bp to ~1280bp (only the 109F/1391R primer set was used to give sequence 
data). If this was achieved the ‘known’ sequence could then become better defined, 
giving us a potential insight into its phylogeny and possibly its functionality and role 
within the human gastrointestinal tract.
5.4.2.1 Sequences from the 109F/1391R Primer Set
Sequences belonging to the inserted PCR products from the ‘selected’ 109F/1391R 
transformants were analysed, with the results placed in Table 5.3-C. Sequences that 
belonged to Firmicutes were highlighted, these sequences were then picked to 
undergo alignment in ClustalW2 with the ‘known’ sequence representative: DM1 
consensus. The result of this alignment is given in the form of a phylogram in Figure 
5.3-C, which depicts the ‘relatedness’ of the sequences.
Of the 33 sequences found in Table 5.3-C, just 2 (6%) belonged to the Firmicutes
Division with both belonged to the Clostridium Genus. The ClustalW2 alignment of 
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all the highlighted Firmicute sequences in Table 5.3-C are represented in the 
phylogram in Figure 5.3-C. The phylogram supports the BLAST and Classifier 
results from Table 5.3-C, the DM1 sequence is grouped alone; the other sequences 
are both Clostridia and group together. 
Designed to target and 3’ extended version of the ‘known’ sequence it would appear 
that the 109F/1391R primer set failed to reach its goal. Unfortunately the primer set 
amplified relevant Firmicute sequences poorly.
-95-
5.5 Conclusion
Overall the attempt to amplify and sequence an extended version of the ~830bp novel 
Mollicute-like 16S rRNA gene sequence uncovered in the preliminary work carried 
out by (Kubs & Musgrave, 2007) was unsuccessful. Without this extended version 
our aim to further characterise the novel Mollicute-like sequence was severely 
hindered.
Primer specificity is a prime candidate for the reasoning behind our failure, with non-
specific amplification prevalent with both primer sets. Despite the high specificity of 
at least one primer in each set (109F/ 927R or 927R NEW) and our attempts to select, 
purify and ‘screen’ PCR products prior to sequencing, only a small amount of 
relevant sequences were found, the majority of which were amplified by the primer 
sets 1AF/927R or 927R NEW, which were designed to amplify an extended 5’ end of 
the ‘known’ sequence.
The primer set 109F/1391R which was designed to target the extended 3’ end of the 
‘known’ sequence found only a small percentage of relevant sequences. This is most 
likely due to the size of the desired amplicon, the large amount of non-specific 
amplification, the lack of a clear cut amplicon at the desired size and the fact that the 
entire raw PCR product was cloned into transformants, with many inserts being 
irrelevant.
It is also important to keep in mind that the segments of the sequences found in this 
study, that were submitted may have contained part of the ‘known’ sequence. But, 
when aligned with other sequences in the BLAST or Classifier databases, the other 
regions of the sequence aligned better with results less related to the results ‘hit’ by 
the ‘known’ sequence representative, DM1 consensus. This is only a possibility and 
is less than likely to be true.
The inability to amplify any full-length versions of the Mollicute-like sequences was 
surprising as the 109F/927R primer set gave consistently strong results: an amplicon 
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at ~830bp (Kubs & Musgrave, 2007). Even though one of these primers (or 
modifications of: 927R NEW) was used in conjunction with a newly designed primer 
(1AF or 1391R), we were still unable to characterise a full-length 16S sequence.
The ‘consensus’ sequence was classified as belonging to the Mollicute Genus, 
Anaeroplasma, with 94% confidence, even so, this still suggests this organism could 
be somewhat more distantly related to the Anaeroplasmas than previously thought. It 
could be that the outer regions of sequence (5’ and 3’ ends) could have little 
homology with Anaeroplasma and this organism is in fact even more novel than 
earlier contemplated. With this in mind, the design of our primers may have been 
misguided as we used Anaeroplasma and other sequences that were within their Class 
and also sequences that were best BLAST ‘hits’ with the ‘consensus’ sequence.
(Eckburg et al., 2005) amplified and sequenced a large percentage of Mollicute
sequences in the human gut microflora using universal primers. (R. E. Ley et al., 
2005; R. E.  Ley et al., 2006) also found similar sequences in the human and mouse 
gut. In preliminary work by (Kubs & Musgrave, 2007) these Mollicute-like sequences 
of interest were found in nearly all of the samples from different regions of the human 
gastrointestinal tract. All of these results suggest that Mollicutes are a major 
component of the human microflora and are there and available to amplify.
The plethora of different environments within the gastrointestinal tract and the 
diversity of the species that inhabit them, are just some of the factors that contribute 
to the difficulty associated with studying the gut microflora. This study was 
metagenomic in nature, and regrettably our task may have been on a too grander 
scale.  Possibly, with more time and labour we would have been able to sequence 
more inserts, as only a small amount was done, and possibly this would have led to 
the discovery of the extended version of the ‘known’ sequence amongst these, 
allowing us to further characterise the targeted novel Mollicute-like sequence and 
ultimately help define its functionality.
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The human gut microflora is poorly explored and ill-defined to date, with more 
studies carried out with the same intent as this one, the microflora and its 
functionality will surely become better defined, opening up numerous options in 
respect to human health.
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5.6 Future Work
The primers were the most likely reason that the attempt to amplify an extended 
version of the novel Mollicute-like sequence at both the 5’ and 3’ ends was ultimately 
unsuccessful. It would be best for future work to focus on designing and testing better 
primers at each of the 5’ and 3’ ends.
Future primer design could involve: finding a larger quantity of relevant sequences 
and sequences found in the human gut; it might even be interesting to look into some 
generic primers and modifying them; reducing the size of the extended ends and 
looking for other primer target regions closer to the ‘known’ sequence could also be 
advantageous.
Perhaps, if more sequencing was carried out on a larger scale it could be possible that 
the 5’ end could be deduced, as this study showed that the ‘screening’ of 1AF/927R 
or 927R NEW transformants was valid and gave relevant, related results.
The ‘screening’ method did not work as well for the 109F/1391R transformants, it 
could be possible that total abandonment of this method could assist in determining 
the 3’ end of the ‘known’ sequence. Thorough sequencing all of the PCR products 
inserted into transformants could reveal the targeted 3’ extended sequence.
Pyrosequencing of the microflora and searching the sequences for the ‘known’ 
sequence could also be possible. Use of probes and hybridization could also assist in 
finding and defining ‘full-length’ versions of these Mollicute-like sequences.
With the increased interest in defining the human gut microflora, and an ever 
increasing range of metagenomic techniques, it is only a matter of time before this 
novel Mollicute-like sequence can be determined.
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